isoproterenol has been researched along with Heart Diseases in 307 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
Excerpt | Relevance | Reference |
---|---|---|
"Milrinone and isoprenaline both significantly increases action potential triangulation during hypothermia, and thereby the risk of ventricular arrhythmias." | 8.31 | Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study. ( Burton, F; Dietrichs, ES; Ghasemi, M; Selli, AL; Smith, G; Watters, T, 2023) |
" This study aimed to evaluate protective effect of ergosterol (ER) on isoproterenol (ISO)-induced myocardial cardiotoxicity." | 7.96 | Ergosterol Attenuates Isoproterenol-Induced Myocardial Cardiotoxicity. ( Dai, C; Gao, Y; Jin, L; Li, S; Song, J; Xie, Q, 2020) |
"In this study, we applied different sizes of gold nanoparticles (Au-NPs) to isoproterenol (ISO)-induced hyperthyroid heart disease rats (HHD rats)." | 7.88 | Size dependent effects of Gold Nanoparticles in ISO-induced Hyperthyroid Rats. ( Ma, A; Ni, Y; Ning, F; Shang, L; Xue, Y; Zhang, J, 2018) |
"Cardiac fibrosis was induced by subcutaneous isoproterenol (ISO) injection, and rapamycin was simultaneously administered orally for 14 days." | 7.81 | Toll-like receptor 4 knockout protects against isoproterenol-induced cardiac fibrosis: the role of autophagy. ( Dong, RQ; Gu, HR; Hu, ZW; Wang, ZF; Wu, YQ; Xie, J; Zhao, C, 2015) |
") juice (PJ) on heart weight, infarct size, plasma marker enzymes of cardiac damage, lipid peroxidation, endogenous enzymatic and non-enzymatic antioxidants, cardiac ATPases and histopathology of isoproterenol (IP)-induced cardiac necrosis (CN) in rats." | 7.76 | Pomegranate (Punica granatum L.) juice supplementation attenuates isoproterenol-induced cardiac necrosis in rats. ( Devkar, RV; Jadeja, RN; Patel, DK; Ramachandran, AV; Thounaojam, MC, 2010) |
"Isoproterenol produces myocardial necrosis in rats." | 7.67 | Protection against isoproterenol-induced myocardial necrosis in rats by 6-mercaptopurine and 6-thioguanine or by irradiation. ( Balazs, T; Joseph, X, 1989) |
"Lycorine is an alkaloid with several beneficial biological properties." | 5.62 | Lycorine ameliorates isoproterenol-induced cardiac dysfunction mainly via inhibiting inflammation, fibrosis, oxidative stress and apoptosis. ( Fu, Y; Li, P; Wang, ZH; Wu, J; Wu, YX; Wu, ZX, 2021) |
"Cardiac fibrosis is a pathological hallmark of progressive heart diseases currently lacking effective treatment." | 5.62 | Nicotinamide mononucleotide attenuates isoproterenol-induced cardiac fibrosis by regulating oxidative stress and Smad3 acetylation. ( Li, B; Li, J; Lin, Q; Liu, N; Liu, Q; Tu, T; Wu, K; Xiao, Y; Xu, W; Zhang, B; Zuo, W, 2021) |
"Cardiac fibrosis is a significant global health problem with limited treatment choices." | 5.46 | Imatinib attenuates cardiac fibrosis by inhibiting platelet-derived growth factor receptors activation in isoproterenol induced model. ( Chen, GX; Fan, T; Hou, J; Liang, MY; Wang, LX; Wu, ZK; Yang, X; Yue, Y, 2017) |
" Here, we have investigated the effects and potential mechanisms of action of MgIG, with respect to myocardial fibrosis induced by isoproterenol (ISO) in mice." | 4.98 | Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4/NF-κB signaling pathway in mice. ( Chu, L; Han, X; Ma, D; Song, T; Zhang, J; Zhang, X; Zhang, Y, 2018) |
"Milrinone and isoprenaline both significantly increases action potential triangulation during hypothermia, and thereby the risk of ventricular arrhythmias." | 4.31 | Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study. ( Burton, F; Dietrichs, ES; Ghasemi, M; Selli, AL; Smith, G; Watters, T, 2023) |
" From day 6, the mice were injected with the nonselective β-agonist isoproterenol for 4 consecutive days to induce diastolic dysfunction and subendocardial fibrosis while maintaining systolic function." | 4.02 | Liver X Receptor Agonist AZ876 Induces Beneficial Endogenous Cardiac Lipid Reprogramming and Protects Against Isoproterenol-Induced Cardiac Damage. ( Beyhoff, N; Blumrich, A; Foryst-Ludwig, A; Goeritzer, M; Grune, J; Jaeger, C; Kasch, J; Kintscher, U; Klopfleisch, R; Luettges, K; Müller, OJ; Ritter, D; Smeir, E; Thiele, A, 2021) |
" This study aimed to evaluate protective effect of ergosterol (ER) on isoproterenol (ISO)-induced myocardial cardiotoxicity." | 3.96 | Ergosterol Attenuates Isoproterenol-Induced Myocardial Cardiotoxicity. ( Dai, C; Gao, Y; Jin, L; Li, S; Song, J; Xie, Q, 2020) |
"The present study aimed at investigating the effect and mechanism of lncRNA Growth Arrest-Specific 5 (GAS5) in cardiac fibrosis induced by isoproterenol (ISO) in vivo." | 3.91 | Overexpression of lncRNA GAS5 attenuates cardiac fibrosis through regulating PTEN/MMP-2 signal pathway in mice. ( Chen, CH; Liu, HL; Sun, YJ, 2019) |
"In this study, we applied different sizes of gold nanoparticles (Au-NPs) to isoproterenol (ISO)-induced hyperthyroid heart disease rats (HHD rats)." | 3.88 | Size dependent effects of Gold Nanoparticles in ISO-induced Hyperthyroid Rats. ( Ma, A; Ni, Y; Ning, F; Shang, L; Xue, Y; Zhang, J, 2018) |
"Cardiac fibrosis was induced by subcutaneous isoproterenol (ISO) injection, and rapamycin was simultaneously administered orally for 14 days." | 3.81 | Toll-like receptor 4 knockout protects against isoproterenol-induced cardiac fibrosis: the role of autophagy. ( Dong, RQ; Gu, HR; Hu, ZW; Wang, ZF; Wu, YQ; Xie, J; Zhao, C, 2015) |
") juice (PJ) on heart weight, infarct size, plasma marker enzymes of cardiac damage, lipid peroxidation, endogenous enzymatic and non-enzymatic antioxidants, cardiac ATPases and histopathology of isoproterenol (IP)-induced cardiac necrosis (CN) in rats." | 3.76 | Pomegranate (Punica granatum L.) juice supplementation attenuates isoproterenol-induced cardiac necrosis in rats. ( Devkar, RV; Jadeja, RN; Patel, DK; Ramachandran, AV; Thounaojam, MC, 2010) |
" The cardiotoxicity was induced by myocardial infarction through subcutaneous administration of isoproterenol hydrochloride for 2 days using 0." | 3.73 | Efficacy of mangiferin on serum and heart tissue lipids in rats subjected to isoproterenol induced cardiotoxicity. ( Nair, PS; Shyamala Devi, CS, 2006) |
"This study was designed to evaluate the cardioprotective potential of naringin on lipid peroxides, enzymatic and nonenzymatic antioxidants and histopathological findings in isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 3.73 | Preventive effect of naringin on lipid peroxides and antioxidants in isoproterenol-induced cardiotoxicity in Wistar rats: biochemical and histopathological evidences. ( Rajadurai, M; Stanely Mainzen Prince, P, 2006) |
"Isoproterenol produces myocardial necrosis in rats." | 3.67 | Protection against isoproterenol-induced myocardial necrosis in rats by 6-mercaptopurine and 6-thioguanine or by irradiation. ( Balazs, T; Joseph, X, 1989) |
" Mental stimulation or isoproterenol, and, respectively, pain or beta blockade induce changes of the repolarization phase divergent from steady state." | 3.65 | Stress-induced and sympathetically-mediated electrocardiographic and circulatory variations in the primary hyperkinetic heart syndrome. ( Fiorentini, C; Guazzi, M; Magrini, F; Olivari, MT; Polese, A, 1975) |
"Lidocaine was ineffective or had deleterious effects in 15 patients where electrical cardioversion required repeated use with an average of 5 times/patient." | 2.38 | Torsade de pointe. Report of 18 cases. ( Araoya, M; Chalak, W; Rifaat, M; Taha, A, 1993) |
"Cardiac fibrosis is a pathological hallmark of progressive heart diseases currently lacking effective treatment." | 1.62 | Nicotinamide mononucleotide attenuates isoproterenol-induced cardiac fibrosis by regulating oxidative stress and Smad3 acetylation. ( Li, B; Li, J; Lin, Q; Liu, N; Liu, Q; Tu, T; Wu, K; Xiao, Y; Xu, W; Zhang, B; Zuo, W, 2021) |
"Lycorine is an alkaloid with several beneficial biological properties." | 1.62 | Lycorine ameliorates isoproterenol-induced cardiac dysfunction mainly via inhibiting inflammation, fibrosis, oxidative stress and apoptosis. ( Fu, Y; Li, P; Wang, ZH; Wu, J; Wu, YX; Wu, ZX, 2021) |
" Wistar rats were dosed once with either isoproterenol (1." | 1.48 | miR-21-5p as a potential biomarker of inflammatory infiltration in the heart upon acute drug-induced cardiac injury in rats. ( De Ron, P; Fleming, A; Fleurance, R; Gryshkova, V; McGhan, P; Nogueira da Costa, A; Valentin, JP, 2018) |
"Cardiac fibrosis is a significant global health problem with limited treatment choices." | 1.46 | Imatinib attenuates cardiac fibrosis by inhibiting platelet-derived growth factor receptors activation in isoproterenol induced model. ( Chen, GX; Fan, T; Hou, J; Liang, MY; Wang, LX; Wu, ZK; Yang, X; Yue, Y, 2017) |
"Cardiotoxicity is one of the most serious side effects of new drugs." | 1.46 | Screening, verification, and analysis of biomarkers for drug-induced cardiac toxicity in vitro based on RTCA coupled with PCR Array technology. ( Cheng, XL; Ren, YR; Xu, MX; Yin, QS; Zhang, L; Zhang, YJ; Zhu, CY; Zhuang, PW, 2017) |
"Carnitine deficiency was induced in Wistar rats by adding 20 mmol/L of sodium pivalate to drinking water (P)." | 1.43 | A Moderate Carnitine Deficiency Exacerbates Isoproterenol-Induced Myocardial Injury in Rats. ( Arduini, A; Bonomini, M; Giudice, PL, 2016) |
"Treatment of genistein could suppress the expression of mitochondrial pro-apoptotic proteins including Bad, caspase-8, caspase-9, and caspase-3 in H9c2 treated with ISO." | 1.39 | Genistein suppresses the isoproterenol-treated H9c2 cardiomyoblast cell apoptosis associated with P-38, Erk1/2, JNK, and NFκB signaling protein activation. ( Chen, RJ; Chen, TS; Day, CH; Ho, TJ; Hu, WS; Huang, CY; Li, YH; Lin, YM; Tsai, CH; Tsai, FJ, 2013) |
"Severe ketoacidosis induces heart failure and cardiac arrest, but its mechanism is unknown." | 1.38 | Inhibitory effect of β-hydroxybutyric acid on L-type Ca(2+) current under β-adrenergic stimulation in guinea pig cardiac ventricular myocytes. ( Akama, Y; Kimura, J; Kurihara, M, 2012) |
"Valsartan has significant blood pressure lowering effect via modulating renin-angiotensin system although its mechanism of action in isoproterenol (ISO)-induced myocardial injury is largely unknown." | 1.37 | Valsartan, an angiotensin II receptor blocker, attenuates cardiac dysfunction and oxidative stress in isoproterenol-induced cardiotoxicity. ( Arya, DS; Bharti, S; Goyal, S; Sahoo, KC; Sharma, AK, 2011) |
" LG administration decreased the toxic events of lipid peroxidation (TBARS) in both serum and heart tissue, by increasing the level of enzymatic antioxidants and non-enzymatic antioxidants significantly in both heart homogenate and serum sample (p < 0." | 1.37 | Cardioprotective effect of lemon grass as evidenced by biochemical and histopathological changes in experimentally induced cardiotoxicity. ( Gayathri, K; Jayachandran, KS; Rajamanickam, GV; Vasanthi, HR, 2011) |
"Pretreatment with rutin at the dose of 80 mg/kg daily for 42 days to isoproterenol-induced rats prevented all the biochemical alterations." | 1.36 | Protective effects of rutin on mitochondrial damage in isoproterenol-induced cardiotoxic rats: an in vivo and in vitro study. ( Prince, PS; Punithavathi, VR; Shanmugapriya, K, 2010) |
"Quantification of fibrosis is a key parameter in the assessment of the severity of cardiovascular disease and efficacy of future candidate therapies." | 1.35 | Quantification of cardiac fibrosis by colour-subtractive computer-assisted image analysis. ( Gaspard, GJ; Pasumarthi, KB, 2008) |
" In a dose-response study (0." | 1.34 | Characterization of troponin responses in isoproterenol-induced cardiac injury in the Hanover Wistar rat. ( Brady, S; Chen, C; Curtis, M; Evans, G; Griffiths, W; Scudamore, C; Turton, J; Whayman, M; Williams, T; Wilson, S; York, M, 2007) |
" This study indicates the potential for spontaneous reversal of some of epinephrine's toxic effects, and further implies that the loss in adrenergic sensitivity in epinephrine-treated animals may be a desensitization phenomenon, while the alterations in calcium response are less readily reversed." | 1.29 | Spontaneous reversibility of catecholamine-induced cardiotoxicity in rats. ( Billingham, ME; Bristow, MR; Deisher, TA; Fowler, MB; Ginsburg, R, 1995) |
"Iloprost-pretreated animals showed a reduction in the rise in heart-specific isoenzymes CK-MB and LDH1-3 in the serum after isoprenaline application." | 1.28 | Effect of iloprost on serum creatine kinase and lactate dehydrogenase isoenzymes after isoprenaline-induced cardiac damage in rats. ( Bhargava, AS; Günzel, P; Khater, AR; Preus, M, 1990) |
"In contrast, T3-induced cardiac hypertrophy was not accompanied by changes in Gi alpha-mRNA expression." | 1.28 | Isoprenaline-induced increase in mRNA levels of inhibitory G-protein alpha-subunits in rat heart. ( Eschenhagen, T; Mende, U; Nose, M; Schmitz, W; Scholz, H; Warnholtz, A; Wüstel, JM, 1991) |
"Oral flecainide therapy was effective in 33 of 63 patients who had tachycardia and an extranodal accessory connection." | 1.28 | Safety and efficacy of oral flecainide therapy in patients with atrioventricular re-entrant tachycardia. ( Cockrell, JL; Griffin, JC; Helmy, I; Langberg, JJ; Lee, MA; Scheinman, MM; Titus, C, 1991) |
"These findings and clinical studies of mitral regurgitation imply that for assessing resting left ventricular contractility in certain chronic conditions, the use of wall stress rather than pressure may be appropriate in the end-systolic framework." | 1.27 | Applications and limitations of end-systolic measures of ventricular performance. ( Ross, J, 1984) |
" The dose-response curves to cumulative doses of xamoterol, a beta 1-adrenoceptor partial agonist, confirmed that the magnitude of the inotropic response was reduced during beta 1-stimulation in patients with an ejection fraction less than or equal to 35% when compared with patients with a greater ejection fraction." | 1.27 | Left ventricular sensitivity to beta-adrenoceptor-stimulating drugs in patients with ischemic heart disease and varying degrees of ventricular dysfunction. ( Charlier, AA; Hanet, C; Marlow, HF; Pouleur, H; Rousseau, MF, 1987) |
"Carazolol was active at considerably lower doses than pindolol (about 25 times less) and propranolol (about 100 times later)." | 1.26 | Comparative investigation on the cardio-protective action of the beta-blockers carazolol, propranolol and pindolol in rats. ( Bartsch, W; Dietmann, K; Kohler, M; Sponer, G, 1981) |
"Twenty-two patients demonstrated mitral valve prolapse (MVP), implicating primary neurologic disturbances as potential factors in the fatigue and lassitude often associated with MVP." | 1.26 | Adrenergic hyperactivity and cardiac abnormality in primary disorders of sleep. ( Boudoulas, H; Clark, RW; Schaal, SF; Schmidt, HS, 1980) |
"Patients with cardiac disorders have defective parasympathetic control of heart rate." | 1.25 | Impairment of autonomically mediated heart rate control in patients with cardiac dysfunction. ( Beiser, GD; Epstein, SE; Goldstein, RE; Stampfer, M, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 200 (65.15) | 18.7374 |
1990's | 14 (4.56) | 18.2507 |
2000's | 28 (9.12) | 29.6817 |
2010's | 40 (13.03) | 24.3611 |
2020's | 25 (8.14) | 2.80 |
Authors | Studies |
---|---|
Wu, J | 2 |
Fu, Y | 1 |
Wu, YX | 1 |
Wu, ZX | 1 |
Wang, ZH | 1 |
Li, P | 1 |
Alegre, KO | 1 |
Paknejad, N | 1 |
Su, M | 1 |
Lou, JS | 1 |
Huang, J | 1 |
Jordan, KD | 1 |
Eng, ET | 1 |
Meyerson, JR | 1 |
Hite, RK | 1 |
Huang, XY | 1 |
Tóth, K | 1 |
Oroszi, T | 1 |
van der Zee, EA | 1 |
Nyakas, C | 1 |
Schoemaker, RG | 1 |
Hamilton, S | 1 |
Terentyeva, R | 1 |
Bogdanov, V | 1 |
Kim, TY | 1 |
Perger, F | 1 |
Yan, J | 1 |
Ai, X | 1 |
Carnes, CA | 1 |
Belevych, AE | 1 |
George, CH | 1 |
Davis, JP | 1 |
Gyorke, S | 1 |
Choi, BR | 1 |
Terentyev, D | 1 |
Fu, J | 1 |
Li, L | 2 |
Chen, L | 2 |
Su, C | 1 |
Feng, X | 2 |
Huang, K | 1 |
Zhang, L | 2 |
Yang, X | 2 |
Fu, Q | 1 |
Shi, Y | 2 |
Zhao, L | 1 |
Wang, J | 2 |
Liu, S | 3 |
Zhang, Y | 4 |
Qin, Q | 1 |
Goyal, SK | 1 |
Hyder, S | 1 |
Vannan, MA | 1 |
Machino-Ohtsuka, T | 1 |
Minami, K | 1 |
Yamasaki, H | 1 |
Nakatsukasa, T | 1 |
Kawamatsu, N | 1 |
Sato, K | 1 |
Yamamoto, M | 2 |
Maruo, K | 1 |
Ishizu, T | 1 |
Kawakami, Y | 1 |
Ieda, M | 1 |
Yusifov, A | 1 |
Borders, MO | 1 |
DeHoff, MA | 1 |
Polson, SM | 1 |
Schmitt, EE | 1 |
Bruns, DR | 1 |
Wang, X | 3 |
Wei, Z | 1 |
Wang, P | 1 |
Zhou, J | 1 |
Feng, M | 1 |
Li, M | 1 |
Liu, M | 1 |
Zhang, X | 2 |
Gao, F | 1 |
Xing, C | 1 |
Li, J | 3 |
Selli, AL | 1 |
Ghasemi, M | 1 |
Watters, T | 1 |
Burton, F | 1 |
Smith, G | 1 |
Dietrichs, ES | 1 |
Wu, P | 1 |
Zhang, Z | 1 |
Ma, G | 1 |
Zhou, W | 1 |
Xie, Q | 1 |
Li, S | 1 |
Gao, Y | 1 |
Jin, L | 1 |
Dai, C | 1 |
Song, J | 1 |
Grant, MKO | 1 |
Abdelgawad, IY | 1 |
Lewis, CA | 1 |
Seelig, D | 1 |
Zordoky, BN | 1 |
Hasan, R | 1 |
Lasker, S | 1 |
Hasan, A | 1 |
Zerin, F | 1 |
Zamila, M | 1 |
Chowdhury, FI | 1 |
Nayan, SI | 1 |
Rahman, MM | 1 |
Khan, F | 1 |
Subhan, N | 1 |
Alam, MA | 1 |
Takahara, S | 1 |
Ferdaoussi, M | 1 |
Srnic, N | 1 |
Maayah, ZH | 1 |
Soni, S | 1 |
Migglautsch, AK | 1 |
Breinbauer, R | 1 |
Kershaw, EE | 1 |
Dyck, JRB | 1 |
Kumar, R | 1 |
Bhargava, P | 1 |
Suchal, K | 1 |
Bhatia, J | 1 |
Arya, DS | 5 |
Huang, T | 1 |
Xie, H | 1 |
Wu, K | 1 |
Li, B | 1 |
Lin, Q | 1 |
Xu, W | 1 |
Zuo, W | 1 |
Liu, N | 1 |
Tu, T | 1 |
Zhang, B | 2 |
Xiao, Y | 1 |
Liu, Q | 1 |
Zhu, JX | 1 |
Ling, W | 1 |
Xue, C | 1 |
Zhou, Z | 2 |
Zhang, YS | 1 |
Yan, C | 1 |
Wu, MP | 1 |
Rababa'h, AM | 1 |
Alzoubi, MA | 1 |
Peter, AK | 1 |
Walker, CJ | 1 |
Ceccato, T | 1 |
Trexler, CL | 1 |
Ozeroff, CD | 1 |
Lugo, KR | 1 |
Perry, AR | 1 |
Anseth, KS | 1 |
Leinwand, LA | 1 |
Ritter, D | 1 |
Goeritzer, M | 1 |
Thiele, A | 1 |
Blumrich, A | 1 |
Beyhoff, N | 1 |
Luettges, K | 1 |
Smeir, E | 1 |
Kasch, J | 1 |
Grune, J | 1 |
Müller, OJ | 1 |
Klopfleisch, R | 1 |
Jaeger, C | 1 |
Foryst-Ludwig, A | 1 |
Kintscher, U | 1 |
Feng, K | 1 |
Liu, Y | 2 |
Sun, J | 1 |
Zhao, C | 2 |
Duan, Y | 1 |
Wang, W | 1 |
Yan, K | 1 |
Yan, X | 1 |
Sun, H | 1 |
Hu, Y | 1 |
Han, J | 1 |
Fang, H | 1 |
Yu, YH | 1 |
Liu, SX | 1 |
Yang, ZQ | 1 |
Kossack, M | 1 |
Hein, S | 1 |
Juergensen, L | 1 |
Siragusa, M | 1 |
Benz, A | 1 |
Katus, HA | 1 |
Most, P | 1 |
Hassel, D | 1 |
Wang, LX | 1 |
Yue, Y | 1 |
Fan, T | 1 |
Hou, J | 1 |
Chen, GX | 1 |
Liang, MY | 1 |
Wu, ZK | 1 |
Yang, J | 1 |
Chen, H | 1 |
Chen, Y | 1 |
Yang, B | 1 |
Tang, F | 1 |
Jiang, Z | 1 |
Tan, W | 1 |
Long, J | 1 |
Chu, C | 1 |
Ma, D | 1 |
Zhang, J | 4 |
Han, X | 1 |
Song, T | 1 |
Chu, L | 1 |
Gryshkova, V | 1 |
Fleming, A | 1 |
McGhan, P | 1 |
De Ron, P | 1 |
Fleurance, R | 1 |
Valentin, JP | 1 |
Nogueira da Costa, A | 1 |
Menhaji-Klotz, E | 1 |
Hesp, KD | 1 |
Londregan, AT | 1 |
Kalgutkar, AS | 1 |
Piotrowski, DW | 1 |
Boehm, M | 1 |
Song, K | 1 |
Ryder, T | 1 |
Beaumont, K | 1 |
Jones, RM | 1 |
Atkinson, K | 1 |
Brown, JA | 1 |
Litchfield, J | 1 |
Xiao, J | 1 |
Canterbury, DP | 1 |
Burford, K | 1 |
Thuma, BA | 1 |
Limberakis, C | 1 |
Jiao, W | 1 |
Bagley, SW | 1 |
Agarwal, S | 1 |
Crowell, D | 1 |
Pazdziorko, S | 1 |
Ward, J | 1 |
Price, DA | 1 |
Clerin, V | 1 |
Xue, Y | 1 |
Ni, Y | 1 |
Ning, F | 1 |
Shang, L | 1 |
Ma, A | 1 |
Naderi-Boldaji, V | 1 |
Joukar, S | 1 |
Noorafshan, A | 1 |
Bahreinipour, MA | 1 |
Dai, H | 1 |
Gao, D | 1 |
Fei, A | 1 |
Chen, MH | 1 |
Liu, JC | 1 |
Hu, YC | 1 |
Cai, XF | 1 |
Yin, DC | 1 |
Alemasi, A | 1 |
Cao, N | 1 |
An, X | 1 |
Gu, H | 1 |
Yu, H | 1 |
Song, Y | 1 |
Wang, H | 1 |
Xiao, H | 1 |
Gao, W | 1 |
Liu, HL | 1 |
Chen, CH | 1 |
Sun, YJ | 1 |
El-Tantawy, WH | 1 |
Sucharov, CC | 1 |
Hijmans, JG | 1 |
Sobus, RD | 1 |
Melhado, WF | 1 |
Miyamoto, SD | 1 |
Stauffer, BL | 1 |
Hu, WS | 1 |
Lin, YM | 1 |
Ho, TJ | 1 |
Chen, RJ | 1 |
Li, YH | 1 |
Tsai, FJ | 1 |
Tsai, CH | 1 |
Day, CH | 1 |
Chen, TS | 1 |
Huang, CY | 1 |
Cai, H | 1 |
Zhang, G | 1 |
Chen, W | 1 |
Chang, J | 1 |
Tang, C | 2 |
Qi, Y | 1 |
Yin, X | 1 |
Sahu, BD | 1 |
Putcha, UK | 1 |
Kuncha, M | 1 |
Rachamalla, SS | 1 |
Sistla, R | 1 |
Dong, RQ | 1 |
Wang, ZF | 1 |
Gu, HR | 1 |
Hu, ZW | 1 |
Xie, J | 1 |
Wu, YQ | 1 |
Yadav, CH | 1 |
Najmi, AK | 1 |
Akhtar, M | 1 |
Khanam, R | 1 |
Baker, CN | 1 |
Gidus, SA | 1 |
Price, GF | 1 |
Peoples, JN | 1 |
Ebert, SN | 1 |
Sprenger, JU | 1 |
Perera, RK | 1 |
Steinbrecher, JH | 1 |
Lehnart, SE | 1 |
Maier, LS | 1 |
Hasenfuss, G | 1 |
Nikolaev, VO | 1 |
Shukla, SK | 1 |
Sharma, SB | 1 |
Singh, UR | 1 |
Ahmad, S | 1 |
Dwivedi, S | 1 |
Giudice, PL | 1 |
Bonomini, M | 1 |
Arduini, A | 1 |
Zhang, Q | 1 |
Deng, Y | 2 |
Lai, W | 1 |
Guan, X | 1 |
Sun, X | 2 |
Han, Q | 1 |
Wang, F | 1 |
Pan, X | 1 |
Ji, Y | 1 |
Luo, H | 1 |
Huang, P | 1 |
Tang, Y | 1 |
Gu, L | 1 |
Dan, G | 1 |
Yu, J | 1 |
Namaka, M | 1 |
Li, X | 1 |
Akila, P | 1 |
Asaikumar, L | 1 |
Vennila, L | 1 |
Xu, MX | 1 |
Yin, QS | 1 |
Zhu, CY | 1 |
Cheng, XL | 1 |
Ren, YR | 1 |
Zhuang, PW | 1 |
Zhang, YJ | 1 |
Schultze, AE | 2 |
Konrad, RJ | 1 |
Credille, KM | 1 |
Lu, QA | 1 |
Todd, J | 1 |
Mladenka, P | 1 |
Zatloukalová, L | 1 |
Simůnek, T | 1 |
Bobrovová, Z | 1 |
Semecký, V | 1 |
Nachtigal, P | 1 |
Hasková, P | 1 |
Macková, E | 1 |
Vávrová, J | 1 |
Holecková, M | 1 |
Palicka, V | 1 |
Hrdina, R | 1 |
Srivastava, G | 1 |
Mehta, JL | 1 |
Engle, SK | 1 |
Jordan, WH | 1 |
Pritt, ML | 1 |
Chiang, AY | 1 |
Davis, MA | 1 |
Zimmermann, JL | 1 |
Rudmann, DG | 1 |
Heinz-Taheny, KM | 1 |
Irizarry, AR | 1 |
Yamamoto, Y | 1 |
Mendel, D | 1 |
Cornwell, PD | 1 |
Watson, DE | 2 |
Rodgers, BD | 1 |
Interlichia, JP | 1 |
Garikipati, DK | 1 |
Mamidi, R | 1 |
Chandra, M | 1 |
Nelson, OL | 1 |
Murry, CE | 1 |
Santana, LF | 1 |
Valdivia, HH | 1 |
Sunmonu, TO | 1 |
Afolayan, AJ | 1 |
Jadeja, RN | 1 |
Thounaojam, MC | 1 |
Patel, DK | 1 |
Devkar, RV | 1 |
Ramachandran, AV | 1 |
Punithavathi, VR | 1 |
Shanmugapriya, K | 1 |
Prince, PS | 2 |
Gayathri, K | 1 |
Jayachandran, KS | 1 |
Vasanthi, HR | 1 |
Rajamanickam, GV | 1 |
Sachdeva, J | 1 |
Tanwar, V | 1 |
Golechha, M | 2 |
Siddiqui, KM | 1 |
Nag, TC | 1 |
Ray, R | 1 |
Kumari, S | 3 |
Hori, Y | 1 |
Yoshioka, K | 1 |
Kanai, K | 1 |
Hoshi, F | 1 |
Itoh, N | 1 |
Higuchi, S | 1 |
Goyal, S | 2 |
Bharti, S | 2 |
Sahoo, KC | 1 |
Sharma, AK | 1 |
Malik, S | 1 |
Ojha, SK | 1 |
Nepali, S | 1 |
Singh, V | 1 |
Ojha, S | 1 |
von Lueder, TG | 1 |
Gravning, J | 1 |
How, OJ | 1 |
Vinge, LE | 1 |
Ahmed, MS | 1 |
Krobert, KA | 1 |
Levy, FO | 1 |
Larsen, TS | 1 |
Smiseth, OA | 1 |
Aasum, E | 1 |
Attramadal, H | 1 |
Chen, S | 1 |
Du, J | 1 |
Liang, Y | 1 |
Zhang, R | 1 |
Jin, H | 1 |
Kurihara, M | 1 |
Akama, Y | 1 |
Kimura, J | 1 |
Panda, S | 1 |
Kar, A | 1 |
Sharma, P | 1 |
Sharma, A | 1 |
Li, Y | 1 |
Wang, L | 1 |
Kang, YJ | 1 |
RONA, G | 6 |
CHAPPEL, CI | 4 |
BALAZS, T | 5 |
GAUDRY, R | 2 |
TOBIASCH, V | 1 |
KRICKAU, G | 1 |
KRASNOW, N | 1 |
ROLETT, E | 1 |
YURCHAK, PM | 1 |
GORLIN, R | 3 |
GANDEVIA, B | 1 |
ROGERS, N | 1 |
MITSUSE, J | 1 |
PIPITONE, V | 1 |
RUSSO, R | 1 |
CARROZZO, M | 1 |
DEVANNA, F | 1 |
DESTASIO, G | 1 |
GOODWIN, JF | 1 |
KAHN, DS | 2 |
O'CONNOR, R | 1 |
STIER, RA | 1 |
ROSENBROOK, W | 1 |
ERICKSON, RW | 1 |
FERRANS, VJ | 3 |
HIBBS, RG | 2 |
BLACK, WC | 1 |
WEILBAECHER, DG | 1 |
GOYER, RA | 1 |
YIN, MW | 1 |
BOWDEN, DH | 1 |
MCLAUGHLIN, JS | 1 |
MORROW, AG | 1 |
BUCKLEY, MJ | 1 |
ROSENBLUM, I | 3 |
WOHL, A | 3 |
STEIN, AA | 3 |
WIGLE, ED | 1 |
DAVID, PR | 1 |
LABROOSE, CJ | 1 |
MCMEEKAN, J | 1 |
KLEIN, MD | 1 |
LANE, FJ | 1 |
KORB, G | 1 |
FRYE, RL | 1 |
KINCAID, OW | 1 |
SWAN, HJ | 1 |
KIRKLIN, JW | 1 |
STRUBELT, O | 2 |
BREINING, H | 2 |
BEZNAK, M | 1 |
HACKER, P | 1 |
Gatzoulis, K | 1 |
Sideris, S | 1 |
Theopistou, A | 1 |
Sotiropoulos, H | 1 |
Stefanadis, C | 1 |
Toutouzas, P | 1 |
Nava, S | 1 |
Mont, L | 1 |
Silva, RM | 1 |
Rogel, U | 1 |
Osorio, P | 1 |
Bartholomay, E | 1 |
Berruezo, A | 1 |
Chueca, E | 1 |
Brugada, J | 1 |
Cano-Martínez, A | 1 |
Vargas-González, A | 1 |
Guarner-Lans, V | 1 |
Prado-Zayago, E | 1 |
Taggart, P | 1 |
Hall, L | 1 |
Bryant, S | 1 |
Sansone, J | 1 |
Kemmerer, M | 1 |
Herlich, J | 1 |
Lord, P | 1 |
Rhoden, CR | 1 |
Wellenius, GA | 1 |
Ghelfi, E | 1 |
Lawrence, J | 1 |
González-Flecha, B | 1 |
Sun, Y | 1 |
Weber, KT | 1 |
Padmanabhan, M | 2 |
Yogeeta, SK | 1 |
Raghavendran, HR | 1 |
Gnanapragasam, A | 1 |
Subhashini, R | 1 |
Devaki, T | 1 |
Dvorak, L | 1 |
Pirk, J | 1 |
Cerny, S | 1 |
Kovar, J | 1 |
Nair, PS | 1 |
Shyamala Devi, CS | 1 |
Rajadurai, M | 1 |
Stanely Mainzen Prince, P | 1 |
Jin, YT | 2 |
Hasebe, N | 2 |
Matsusaka, T | 1 |
Natori, S | 2 |
Ohta, T | 2 |
Tsuji, S | 2 |
Kikuchi, K | 2 |
Mainzen Prince, PS | 1 |
Berna, MJ | 1 |
Zhen, Y | 1 |
Hale, JE | 1 |
Ackermann, BL | 1 |
York, M | 1 |
Scudamore, C | 1 |
Brady, S | 1 |
Chen, C | 1 |
Wilson, S | 1 |
Curtis, M | 1 |
Evans, G | 1 |
Griffiths, W | 1 |
Whayman, M | 1 |
Williams, T | 1 |
Turton, J | 1 |
Ferreira, AJ | 1 |
Oliveira, TL | 1 |
Castro, MC | 1 |
Almeida, AP | 1 |
Castro, CH | 1 |
Caliari, MV | 1 |
Gava, E | 1 |
Kitten, GT | 1 |
Santos, RA | 1 |
McGaff, CJ | 1 |
Roveti, GC | 1 |
Glassman, E | 1 |
Milnor, WR | 1 |
Gaspard, GJ | 1 |
Pasumarthi, KB | 1 |
Gál, G | 2 |
Leszkovszky, G | 1 |
Lendvai, J | 1 |
Benchimol, A | 1 |
Ellis, JG | 1 |
Van Metre, TE | 1 |
Pearl, W | 1 |
Stanton, HC | 2 |
Schwartz, A | 2 |
Tikoff, G | 1 |
Schmidt, AM | 1 |
Tsagaris, TJ | 1 |
Bartsch, W | 1 |
Sponer, G | 1 |
Dietmann, K | 1 |
Kohler, M | 1 |
Ross, J | 1 |
Ginsburg, R | 2 |
Bristow, MR | 2 |
Billingham, ME | 2 |
Stinson, EB | 1 |
Schroeder, JS | 1 |
Harrison, DC | 4 |
Ogawa, K | 1 |
Mizuguchi, I | 1 |
Ban, M | 1 |
Satake, T | 1 |
Artman, M | 1 |
Parrish, MD | 1 |
Graham, TP | 1 |
Faltová, E | 5 |
Parízková, J | 3 |
Mráz, M | 2 |
Sedivý, J | 2 |
Spátová, M | 1 |
Buxton, AE | 1 |
Waxman, HL | 1 |
Marchlinski, FE | 1 |
Josephson, ME | 1 |
Benchimol, CB | 1 |
Barbosa Filho, J | 1 |
Ginefra, P | 1 |
Benchimol, AB | 1 |
de Carvalho, AP | 1 |
Mitova, M | 2 |
Bednarik, B | 2 |
Macek, M | 1 |
Cerný, E | 1 |
Liu, XJ | 1 |
Wagner, HN | 1 |
Tao, S | 1 |
Clark, RW | 1 |
Boudoulas, H | 1 |
Schaal, SF | 1 |
Schmidt, HS | 1 |
Sasaki, T | 1 |
Matsuzaki, M | 1 |
Takahashi, Y | 1 |
Toma, Y | 1 |
Uchida, T | 1 |
Ogawa, H | 1 |
Naito, H | 1 |
Matsuda, Y | 1 |
Kumada, T | 1 |
Kusukawa, R | 2 |
Lombardini, JB | 1 |
Slutsky, R | 1 |
Chalak, W | 1 |
Taha, A | 1 |
Araoya, M | 1 |
Rifaat, M | 1 |
Moya i Mitjans, A | 1 |
Permanyer Miralda, G | 1 |
Sagristá Sauleda, J | 1 |
Mont Girbau, L | 1 |
Rius Gelabert, T | 1 |
Soler Soler, J | 1 |
Sheldon, R | 1 |
Rose, S | 1 |
Koshman, ML | 1 |
Deisher, TA | 1 |
Fowler, MB | 1 |
Fitzpatrick, AP | 1 |
Lee, RJ | 1 |
Epstein, LM | 1 |
Lesh, MD | 1 |
Eisenberg, S | 1 |
Sheinman, MM | 1 |
Miyazato, H | 1 |
Biro, S | 1 |
Setoguchi, M | 1 |
Maeda, M | 1 |
Tashiro, T | 1 |
Nakao, S | 1 |
Tanaka, H | 2 |
Harding, SE | 1 |
Davies, CH | 1 |
Money-Kyrle, AM | 1 |
Poole-Wilson, PA | 1 |
Bertinchant, JP | 1 |
Robert, E | 1 |
Polge, A | 1 |
Marty-Double, C | 1 |
Fabbro-Peray, P | 1 |
Poirey, S | 1 |
Aya, G | 1 |
Juan, JM | 1 |
Ledermann, B | 1 |
de la Coussaye, JE | 1 |
Dauzat, M | 1 |
Rosenblum, R | 1 |
Berkowitz, WD | 1 |
Lawson, D | 1 |
Meij, JT | 1 |
Sheikh, F | 1 |
Jimenez, SK | 1 |
Nickerson, PW | 1 |
Kardami, E | 1 |
Cattini, PA | 1 |
Kido, S | 1 |
Sato, M | 1 |
Kennedy, RH | 1 |
Stewart, C | 1 |
Light, KE | 1 |
Wyeth, RP | 1 |
Sullivan, L | 1 |
Poupa, O | 5 |
Lindström, L | 1 |
Carlsten, A | 2 |
Diamant-Berger, F | 1 |
Haas, C | 1 |
Kieffer, JP | 1 |
Abry, B | 1 |
Hajjar, R | 1 |
Desnot, F | 1 |
Piwnica, A | 2 |
Dubost, C | 2 |
Zisel'man, SB | 1 |
Sivkov, SI | 1 |
Deehan, R | 2 |
Swanton, JG | 2 |
Woolf, N | 2 |
Davies, MJ | 1 |
Shaw, MJ | 1 |
Trickey, RJ | 1 |
Quinones, MA | 1 |
Gaasch, WH | 1 |
Cole, JS | 1 |
Alexander, JK | 1 |
Yates, JC | 1 |
Dhalla, NS | 3 |
Singh, JN | 1 |
Bajusz, E | 2 |
Jasmin, G | 2 |
Drop, LJ | 1 |
Laver, MB | 1 |
Carpentiere, G | 1 |
Martelli, M | 1 |
Saponaro, A | 1 |
Martinez, R | 1 |
Kroó, M | 1 |
Szilasy, Z | 1 |
Stefan, G | 1 |
Lappas, DG | 1 |
Powell, WM | 1 |
Daggett, WM | 2 |
Bolte, HD | 1 |
Morace, G | 1 |
Padeletti, L | 1 |
Porciani, MC | 1 |
Fantini, F | 1 |
Steinberg, DL | 1 |
Katz, SS | 1 |
Lipman, BS | 1 |
Strozzi, C | 1 |
Cocco, G | 1 |
Padovan, GC | 1 |
Drózdz, M | 1 |
Kucharz, E | 1 |
Wieczorek, M | 1 |
Fleckenstein, A | 3 |
Janke, J | 2 |
Frey, M | 1 |
Hein, B | 2 |
Lossnitzer, K | 1 |
Völger, KD | 1 |
Guggenmos, R | 1 |
Gopinath, C | 1 |
Thuring, J | 1 |
Zayed, I | 1 |
Adams, HR | 1 |
Parker, JL | 1 |
Durrett, LR | 1 |
Mueller, HS | 1 |
Goldstein, RE | 1 |
Beiser, GD | 1 |
Stampfer, M | 1 |
Epstein, SE | 1 |
Van Vleet, JF | 1 |
Rebar, AH | 1 |
Kalmykova, EIu | 1 |
Mueller, EA | 1 |
Griffin, WS | 1 |
Wildenthal, K | 1 |
Steen, E | 1 |
Rosen, D | 1 |
Trickey, R | 1 |
Long, P | 1 |
Miller, AL | 1 |
Rowles, PM | 1 |
Marshall, RC | 1 |
Berger, HJ | 1 |
Costin, JC | 1 |
Freedman, GS | 1 |
Wolberg, J | 1 |
Cohen, LS | 1 |
Gottschalk, A | 1 |
Zaret, BL | 1 |
Finnegan, P | 1 |
Forbes, MV | 1 |
Bishop, JM | 1 |
Weiss, LR | 1 |
Collins, JE | 1 |
Krop, S | 1 |
Harri, MN | 1 |
Baagoe, KH | 1 |
Svec, P | 1 |
Seginko, J | 1 |
Inczinger, F | 5 |
Denef, B | 1 |
Popeye, R | 1 |
Geest, HD | 1 |
Kesteloot, H | 1 |
Belghiti, J | 1 |
Belghiti, D | 1 |
Amedome, A | 1 |
Durand, H | 1 |
Stojanova, D | 1 |
Gudeska, S | 1 |
Glavas, E | 1 |
Nikodijević, B | 1 |
Guazzi, M | 1 |
Fiorentini, C | 1 |
Polese, A | 1 |
Magrini, F | 1 |
Olivari, MT | 1 |
Kopteva, LA | 1 |
Zhevoliukova, LI | 1 |
Grigor'eva, EA | 1 |
Tan, LB | 1 |
Benjamin, IJ | 1 |
Clark, WA | 1 |
Bhargava, AS | 1 |
Preus, M | 1 |
Khater, AR | 1 |
Günzel, P | 1 |
Eschenhagen, T | 1 |
Mende, U | 1 |
Nose, M | 1 |
Schmitz, W | 1 |
Scholz, H | 1 |
Warnholtz, A | 1 |
Wüstel, JM | 1 |
Seliem, MA | 1 |
Benson, DW | 1 |
Strasburger, JF | 1 |
Duffy, CE | 1 |
Cockrell, JL | 1 |
Scheinman, MM | 1 |
Titus, C | 1 |
Helmy, I | 1 |
Langberg, JJ | 1 |
Lee, MA | 1 |
Griffin, JC | 1 |
Sidorenko, BA | 1 |
Surovov, IuA | 1 |
Hanton, G | 1 |
Longeart, L | 1 |
Lodola, A | 1 |
Brown, L | 1 |
Lorenz, B | 1 |
Erdmann, E | 1 |
Joseph, X | 1 |
Pouleur, H | 1 |
Rousseau, MF | 1 |
Hanet, C | 1 |
Marlow, HF | 1 |
Charlier, AA | 1 |
Barbee, RW | 1 |
Shepherd, RE | 1 |
Burns, AH | 1 |
Gøtzsche, O | 1 |
Tisné-Versailles, J | 1 |
Constantin, M | 1 |
Lamar, JC | 1 |
Pourrias, B | 1 |
Sakurai, S | 1 |
Rudolph, AM | 1 |
Sterz, H | 1 |
Pernot, C | 1 |
Henry, M | 1 |
Aigle, JC | 1 |
Jewitt, D | 1 |
Birkhead, J | 1 |
Mitchell, A | 1 |
Dollery, C | 1 |
Tsuboi, T | 2 |
Ishikawa, K | 2 |
Osawa, Y | 2 |
Yoshida, K | 2 |
Shimizu, M | 2 |
Marcano, BA | 1 |
Moss, AJ | 1 |
Frank, MJ | 1 |
Levinson, GE | 2 |
Ueda, H | 2 |
Machida, K | 1 |
Nakanishi, A | 1 |
Ito, I | 1 |
Yasuda, H | 1 |
Jelínková, M | 2 |
Ostádal, B | 2 |
Rychterová, V | 1 |
Leder, O | 3 |
Pelouch, V | 1 |
Deyl, Z | 1 |
Burch, GE | 2 |
Giles, TD | 1 |
Polumbo, RA | 1 |
Leighton, RF | 1 |
Weissler, AM | 1 |
Iskushev, VS | 1 |
Lifshits, RI | 1 |
Slobodin, VB | 1 |
Earl, FL | 1 |
Bierbower, GW | 1 |
Weinberger, MA | 1 |
Leszkovszky, GP | 1 |
Dorigotti, L | 1 |
Gaetani, M | 1 |
Glässer, AH | 1 |
Turolla, E | 1 |
Deptalla, H | 1 |
Wiegershausen, B | 1 |
Martorana, PA | 1 |
Bleifeld, W | 1 |
Merx, W | 1 |
Effert, S | 1 |
Kerber, RE | 1 |
Goldman, RH | 1 |
Alderman, EL | 2 |
Zbinden, G | 1 |
Moe, RA | 1 |
Gryglewski, RJ | 1 |
Kulig, A | 2 |
Kostka-Trabka, E | 2 |
von Egidy, H | 1 |
Baragan, J | 1 |
Kutsuna, F | 1 |
Ahmed, SS | 1 |
Schwartz, CJ | 1 |
Ettinger, PO | 1 |
Fujino, T | 1 |
Mashiba, H | 1 |
Christensen, ER | 1 |
Antonsen, BJ | 1 |
Bózner, A | 2 |
Masáreová, E | 2 |
Lehr, D | 2 |
Seelig, MS | 1 |
King, JF | 1 |
Salel, AF | 1 |
Amsterdam, EA | 1 |
Massumi, RA | 1 |
Zelis, R | 1 |
Mason, DT | 1 |
Osborne, BE | 1 |
Dent, NJ | 1 |
Ahlquist, RP | 1 |
Varley, KG | 1 |
Yoshitake, T | 1 |
Mizuno, A | 1 |
Matsumoto, H | 1 |
Fukushima, K | 1 |
Wójcicki, J | 1 |
Rózewicka, L | 1 |
Samochowiec, L | 1 |
Kadyków, M | 1 |
Pellegrino, PA | 1 |
Bramante, PO | 2 |
Nirdlinger, EL | 2 |
Kaplinsky, E | 1 |
Arora, RB | 1 |
Basu, AK | 1 |
Kapoor, SC | 1 |
Seth, SD | 1 |
Taneja, V | 1 |
Maramaa, SIa | 1 |
Humphries, JO | 1 |
Csapó, Z | 2 |
Dusek, J | 2 |
Harley, A | 1 |
Greenfield, JC | 1 |
Rakusan, K | 1 |
Aschenbrenner, V | 1 |
Mĕstan, J | 1 |
Turek, Z | 1 |
Hugenholtz, PG | 1 |
Wagner, HR | 1 |
Plauth, WH | 1 |
Armstrong, PW | 1 |
Gold, HK | 1 |
Austen, WG | 1 |
Sanders, CA | 1 |
Selve, H | 1 |
Ferrero, C | 1 |
Grimberg, D | 1 |
Acar, J | 1 |
Joly, F | 1 |
Humbert, G | 1 |
Forwand, SA | 1 |
Schatzki, SC | 1 |
Nordberg, ED | 1 |
Kobayashi, K | 1 |
Stolley, PD | 1 |
McGrath, JJ | 2 |
Brown, ML | 2 |
Martin, LG | 1 |
Finegan, RE | 1 |
Marlon, AM | 1 |
Pachinger, O | 1 |
Cagánová, A | 1 |
Kovãcsová, B | 1 |
Edelsteinovă, S | 1 |
Doupovcovă, M | 1 |
Martin, CE | 1 |
Shaver, JA | 1 |
Thompson, ME | 1 |
Reddy, PS | 1 |
Leonard, JJ | 1 |
Leon, AS | 1 |
White, FC | 1 |
Bloor, CM | 1 |
Saviano, MA | 1 |
Gryglewski, R | 1 |
Kowalczykowa, J | 1 |
Swies, J | 1 |
Kozlovský, J | 1 |
Griminger, P | 1 |
Walsh, JJ | 1 |
Hattori, E | 1 |
Yatsuki, K | 1 |
Miyazaki, T | 1 |
Sata, T | 1 |
Nakamura, M | 1 |
Biasco, G | 1 |
Cristallo, E | 1 |
Morin, Y | 1 |
Roy, PE | 1 |
Mohiuddin, SM | 1 |
Taskar, PK | 1 |
Döring, HJ | 1 |
Reindell, A | 1 |
Gomazkov, OA | 1 |
Shimkovich, MV | 1 |
Meerson, FZ | 3 |
Smrz, M | 1 |
Delman, AJ | 1 |
Attai, LA | 1 |
Naidu, S | 1 |
Robinson, G | 1 |
Janiec, W | 1 |
Wolański, A | 1 |
Pasiewicz, J | 1 |
Panchenko, LF | 2 |
Golubeva, LIu | 2 |
Liubimtseva, ON | 2 |
Portenko, NG | 2 |
Kobayashi, T | 1 |
Nakayama, R | 1 |
Kimura, K | 1 |
Yoneyama, T | 1 |
Taylor, SH | 1 |
Majid, PA | 1 |
Dykes, JR | 1 |
Sharma, B | 1 |
Saxton, C | 1 |
Souhrada, J | 1 |
Bullard, RW | 1 |
De Saint Pierre, G | 1 |
Kato, H | 1 |
Hirose, M | 1 |
Yamaguchi, M | 1 |
Yoshizawa, Y | 1 |
Fukuda, H | 1 |
Soyer, R | 1 |
Gandjbakhch, I | 1 |
Virag, R | 1 |
Guery, J | 1 |
Hamladji, O | 1 |
Prigent, C | 1 |
Delair, F | 1 |
Frohlich, ED | 1 |
Tarazi, RC | 1 |
Dustan, HP | 1 |
Luisada, AA | 1 |
Madoery, RJ | 1 |
Kennedy, JH | 1 |
Alousi, M | 1 |
Homi, J | 1 |
Rosén, A | 1 |
Elliott, WC | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Prospective Randomized Placebo-controlled Study of the Effect of Eplerenone on Left Ventricular Diastolic Function in Women Receiving Anthracycline Therapy for Breast Cancer[NCT01708798] | Phase 2/Phase 3 | 44 participants (Actual) | Interventional | 2014-05-31 | Terminated (stopped due to Futility) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
16 reviews available for isoproterenol and Heart Diseases
Article | Year |
---|---|
Isoproterenol-Assisted Differentiation Between Sludge and Organized Thrombus to Guide Left Atrial Appendage Occlusion.
Topics: Atrial Appendage; Atrial Fibrillation; Heart Diseases; Humans; Isoproterenol; Retrospective Studies; | 2023 |
Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4/NF-κB signaling pathway in mice.
Topics: Animals; Anti-Inflammatory Agents; Atrial Natriuretic Factor; bcl-2-Associated X Protein; Creatine K | 2018 |
Currying the heart: curcumin and cardioprotection.
Topics: Adrenergic beta-Agonists; Animals; Antibiotics, Antineoplastic; Cardiovascular Agents; Curcumin; Dox | 2009 |
STUDIES ON INFARCT-LIKE MYOCARDIAL NECROSIS PRODUCED BY ISOPROTERENOL: A REVIEW.
Topics: Desoxycorticosterone; Dogs; Epinephrine; Heart Diseases; Hyperthyroidism; Hypokalemia; Isoproterenol | 1963 |
Congestive heart failure in childhood and adolescence: recognition and management.
Topics: Adolescent; Captopril; Cardiomyopathies; Child; Digoxin; Dobutamine; Dopamine; Echocardiography; Ele | 1983 |
[Dysfunction of the sinus node].
Topics: Animals; Atropine; Electrocardiography; Heart Diseases; Heart Function Tests; Heart Rate; Humans; Is | 1982 |
Torsade de pointe. Report of 18 cases.
Topics: Adult; Aged; Aged, 80 and over; Cardiac Pacing, Artificial; Causality; Combined Modality Therapy; El | 1993 |
Cardiac dysfunction in the perioperative period: pathophysiology, diagnosis, and treatment.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Cardiac Surgical Proce | 1977 |
[Pharmacologic testing of heart function].
Topics: Angiotensins; Atropine; Diagnosis, Differential; Dipyridamole; Dobutamine; Echocardiography; Electro | 1977 |
Early abnormalities in myocardial cell function in experimental diabetes.
Topics: Adenosine Triphosphate; Adult; Animals; Blood Glucose; Calcium; Calcium-Transporting ATPases; Catech | 1986 |
[Beta-receptor-blocking agents and their current clinical significance].
Topics: Adrenal Gland Neoplasms; Amino Alcohols; Angina Pectoris; Anilides; Arrhythmias, Cardiac; Blood Pres | 1968 |
[Catecholamine cardiopathy].
Topics: Adrenal Gland Neoplasms; Adult; Animals; Catecholamines; Cerebrovascular Disorders; Electrocardiogra | 1972 |
[Isoprenaline aerosols in the therapy of acute bronchial obstruction].
Topics: Aerosols; Asthma; Bronchial Diseases; Heart Diseases; Humans; Isoproterenol | 1973 |
[Clinical evaluation of myocardial contractility (author's transl)].
Topics: Animals; Blood Pressure; Cats; Glycosides; Heart; Heart Diseases; Heart Rate; Hemodynamics; Humans; | 1974 |
[The function of the circulatory system].
Topics: Adult; Aminophylline; Angiocardiography; Animals; Blood Circulation; Blood Pressure; Brain Stem; Car | 1969 |
The pluricausal cardiopathies.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Calcinosis; Cardiac Glycosides; Deficiency Diseases; | 1969 |
4 trials available for isoproterenol and Heart Diseases
Article | Year |
---|---|
Short head-up tilt test potentiated with oral nitroglycerine: comparison with a conventional test using isoproterenol.
Topics: Female; Heart Diseases; Humans; Isoproterenol; Male; Middle Aged; Nitroglycerin; Syncope; Tilt-Table | 2004 |
The role of leukocyte depleting filters in heart transplantation: early outcomes in prospective, randomized clinical trial.
Topics: Adult; Biomarkers; Cardiac Pacing, Artificial; Cardiopulmonary Bypass; Chi-Square Distribution; Crea | 2006 |
Effect of patient characteristics on the yield of prolonged baseline head-up tilt testing and the additional yield of drug provocation.
Topics: Age Factors; Aged; Aged, 80 and over; Edrophonium; Female; Heart Diseases; Humans; Isoproterenol; Ma | 1996 |
[Experience with dopamine in heart surgery].
Topics: Cardiac Surgical Procedures; Clinical Trials as Topic; Dopamine; Drug Evaluation; Heart Diseases; Hu | 1978 |
287 other studies available for isoproterenol and Heart Diseases
Article | Year |
---|---|
Lycorine ameliorates isoproterenol-induced cardiac dysfunction mainly via inhibiting inflammation, fibrosis, oxidative stress and apoptosis.
Topics: Amaryllidaceae Alkaloids; Animals; Apoptosis; Cytokines; Fibrosis; Heart; Heart Diseases; Inflammati | 2021 |
Structural basis and mechanism of activation of two different families of G proteins by the same GPCR.
Topics: Animals; Cardiac Output; Cell Line; Cryoelectron Microscopy; Cyclic AMP; Enzyme Activation; GTP-Bind | 2021 |
Effects of exercise training on behavior and brain function after high dose isoproterenol-induced cardiac damage.
Topics: Animals; Anxiety; Brain-Derived Neurotrophic Factor; Cognition; Exploratory Behavior; Heart; Heart D | 2021 |
Ero1α-Dependent ERp44 Dissociation From RyR2 Contributes to Cardiac Arrhythmia.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Calcium Signaling; Heart Diseases; Intracellular Signaling P | 2022 |
PGE2 protects against heart failure through inhibiting TGF-β1 synthesis in cardiomyocytes and crosstalk between TGF-β1 and GRK2.
Topics: Animals; Dinoprostone; Fibrosis; Heart Diseases; Heart Failure; Isoproterenol; Male; Mice; Mice, Inb | 2022 |
The selective NLRP3 inflammasome inhibitor MCC950 improves isoproterenol-induced cardiac dysfunction by inhibiting cardiomyocyte senescence.
Topics: Animals; Furans; Heart Diseases; Heterocyclic Compounds, 4 or More Rings; Hypertrophy; Inflammasomes | 2022 |
Efficacy of Low-Dose Isoproterenol Infusion for the Exclusion of a Left Atrial Appendage Thrombus in Patients With Dense Spontaneous Echo Contrast Caused by Atrial Fibrillation.
Topics: Atrial Appendage; Atrial Fibrillation; Echocardiography, Transesophageal; Heart Diseases; Humans; Is | 2023 |
Juvenile physical activity protects against isoproterenol-induced cardiac dysfunction later in life.
Topics: Animals; Exercise; Female; Fibrosis; Heart Diseases; Isoproterenol; Male; Mice; Motor Activity; Myoc | 2023 |
Echocardiographic evaluation of cardiac reserve to detect subtle cardiac dysfunction in mice.
Topics: Animals; Echocardiography; Female; Heart; Heart Diseases; Heart Function Tests; Isoproterenol; Male; | 2023 |
Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study.
Topics: Cardiotonic Agents; Heart Diseases; Humans; Hydrazones; Hypothermia; Isoproterenol; Milrinone; Myocy | 2023 |
Transcriptomics and metabolomics reveal the cardioprotective effect of Compound Danshen tablet on isoproterenol-induced myocardial injury in high-fat-diet fed mice.
Topics: Animals; Camphanes; Cardiotonic Agents; Diet, High-Fat; Drugs, Chinese Herbal; Gene Expression Profi | 2020 |
Ergosterol Attenuates Isoproterenol-Induced Myocardial Cardiotoxicity.
Topics: Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Cardiotoxicity; Cell Line; Disease | 2020 |
Lack of sexual dimorphism in a mouse model of isoproterenol-induced cardiac dysfunction.
Topics: Animals; Biomarkers; Cardiomegaly; Disease Models, Animal; Echocardiography; Female; Heart Diseases; | 2020 |
Canagliflozin attenuates isoprenaline-induced cardiac oxidative stress by stimulating multiple antioxidant and anti-inflammatory signaling pathways.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Canagliflozin; Disease Models, Animal; H | 2020 |
Inhibition of ATGL in adipose tissue ameliorates isoproterenol-induced cardiac remodeling by reducing adipose tissue inflammation.
Topics: Adipose Tissue, White; Animals; Anti-Inflammatory Agents; Cells, Cultured; Disease Models, Animal; E | 2021 |
Targeting AGE-RAGE signaling pathway by Saxagliptin prevents myocardial injury in isoproterenol challenged diabetic rats.
Topics: Adamantane; Animals; Apoptosis; Diabetes Complications; Diabetes Mellitus, Experimental; Dipeptides; | 2021 |
CTRP12 Alleviates Isoproterenol Induced Cardiac Fibrosis via Inhibiting the Activation of P38 Pathway.
Topics: Adipokines; Animals; Fibroblasts; Fibrosis; Heart Diseases; Humans; Isoproterenol; Male; Mice; Mice, | 2021 |
Nicotinamide mononucleotide attenuates isoproterenol-induced cardiac fibrosis by regulating oxidative stress and Smad3 acetylation.
Topics: Acetylation; Animals; Cardiotonic Agents; Fibrosis; Heart Diseases; Isoproterenol; Male; Mice; Mice, | 2021 |
Higenamine attenuates cardiac fibroblast abstract and fibrosis via inhibition of TGF-β1/Smad signaling.
Topics: Actins; Adrenergic beta-Agonists; Alkaloids; Animals; Aorta; Apoptosis; Cardiomegaly; Fibrinolytic A | 2021 |
Origanum majorana L. Extract Protects Against Isoproterenol-Induced Cardiotoxicity in Rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cardiotoxicity; Disease Models, Animal; | 2021 |
Cardiac Fibroblasts Mediate a Sexually Dimorphic Fibrotic Response to β-Adrenergic Stimulation.
Topics: Adrenergic beta-Agonists; Animals; Disease Models, Animal; Disease Progression; Female; Fibroblasts; | 2021 |
Liver X Receptor Agonist AZ876 Induces Beneficial Endogenous Cardiac Lipid Reprogramming and Protects Against Isoproterenol-Induced Cardiac Damage.
Topics: Aniline Compounds; Animals; Cellular Reprogramming; Disease Models, Animal; Fatty Acids; Fibrosis; H | 2021 |
Compound Danshen Dripping Pill inhibits doxorubicin or isoproterenol-induced cardiotoxicity.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Camphanes; Cardiotoxicity; Cell Line; Di | 2021 |
Liquiritigenin attenuates isoprenaline‑induced myocardial fibrosis in mice through the TGF‑β1/Smad2 and AKT/ERK signaling pathways.
Topics: Angiotensin II; Animals; Apoptosis; Cell Line; Extracellular Signal-Regulated MAP Kinases; Fibrosis; | 2021 |
Induction of cardiac dysfunction in developing and adult zebrafish by chronic isoproterenol stimulation.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Disease Models, Animal; Echocardiography; Heart; Heart D | 2017 |
Imatinib attenuates cardiac fibrosis by inhibiting platelet-derived growth factor receptors activation in isoproterenol induced model.
Topics: Animals; Cell Survival; Cells, Cultured; Echocardiography; Fibrosis; Gene Expression; Heart Diseases | 2017 |
Glycyrrhizic acid attenuates myocardial injury: Involvement of RIP140/NF-kB Pathway.
Topics: Adaptor Proteins, Signal Transducing; Animals; Biomarkers; Cytokines; Gene Expression Regulation; Gl | 2017 |
[Effect of Shexiang Baoxin Pills on isoprenaline-induced myocardial cell hypertrophy and Cx43 expression].
Topics: Connexin 43; Drugs, Chinese Herbal; Heart Diseases; Humans; Hypertrophy; Isoproterenol | 2017 |
miR-21-5p as a potential biomarker of inflammatory infiltration in the heart upon acute drug-induced cardiac injury in rats.
Topics: Allylamine; Animals; Cardiotoxicity; Disease Models, Animal; Gene Expression Profiling; Gene Express | 2018 |
Discovery of a Novel Small-Molecule Modulator of C-X-C Chemokine Receptor Type 7 as a Treatment for Cardiac Fibrosis.
Topics: Acetamides; Animals; Azepines; Cardiotonic Agents; Dogs; Fibrosis; Heart Diseases; Humans; Hydrophob | 2018 |
Size dependent effects of Gold Nanoparticles in ISO-induced Hyperthyroid Rats.
Topics: Administration, Intravenous; Animals; Autophagy-Related Protein 7; Caspase 12; Cell Line; Disease Mo | 2018 |
Limb Blood Flow Restriction Plus Mild Aerobic Exercise Training Protects the Heart Against Isoproterenol-Induced Cardiac Injury in Old Rats: Role of GSK-3β.
Topics: Age Factors; Animals; Disease Models, Animal; Glycogen Synthase Kinase 3 beta; Heart Diseases; Hindl | 2019 |
Phosphocreatine Attenuates Isoproterenol-Induced Cardiac Fibrosis and Cardiomyocyte Apoptosis.
Topics: Animals; Apoptosis; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart Diseases; Hu | 2019 |
MicroRNA-199a regulates myocardial fibrosis in rats by targeting SFRP5.
Topics: 3' Untranslated Regions; Actins; Adipokines; Animals; Antagomirs; Cell Movement; Cell Proliferation; | 2019 |
Exercise Attenuates Acute β-Adrenergic Overactivation-Induced Cardiac Fibrosis by Modulating Cytokines.
Topics: Animals; Cytokines; Disease Models, Animal; Exercise Therapy; Fibrosis; Gene Expression Regulation; | 2019 |
Overexpression of lncRNA GAS5 attenuates cardiac fibrosis through regulating PTEN/MMP-2 signal pathway in mice.
Topics: Actins; Adrenergic beta-Antagonists; Animals; Collagen Type I; Echocardiography; Fibrosis; Heart Dis | 2019 |
Biochemical effects of Solidago virgaurea extract on experimental cardiotoxicity.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Captopril; Cardiotonic Agents; Creatine | 2014 |
β-Adrenergic receptor antagonism in mice: a model for pediatric heart disease.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Child; Disease Models, Animal; Heart; Heart Disease | 2013 |
Genistein suppresses the isoproterenol-treated H9c2 cardiomyoblast cell apoptosis associated with P-38, Erk1/2, JNK, and NFκB signaling protein activation.
Topics: Animals; Apoptosis; bcl-Associated Death Protein; Cardiotonic Agents; Caspases; Cells, Cultured; Dow | 2013 |
Metformin protects the myocardium against isoproterenol-induced injury in rats through alleviating endoplasmic reticulum stress.
Topics: Adrenergic beta-Agonists; AMP-Activated Protein Kinases; Animals; Apoptosis; Blotting, Western; Card | 2014 |
Carnosic acid promotes myocardial antioxidant response and prevents isoproterenol-induced myocardial oxidative stress and apoptosis in mice.
Topics: Abietanes; Active Transport, Cell Nucleus; Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Pr | 2014 |
Toll-like receptor 4 knockout protects against isoproterenol-induced cardiac fibrosis: the role of autophagy.
Topics: Animals; Autophagy; Cardiotonic Agents; Fibrosis; Heart Diseases; Isoproterenol; Male; Mice; Mice, I | 2015 |
Cardioprotective role of H₃R agonist imetit on isoproterenol-induced hemodynamic changes and oxidative stress in rats.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Biomarkers; Blood Pressure; Body Height; Body Weigh | 2015 |
Impaired cardiac energy metabolism in embryos lacking adrenergic stimulation.
Topics: Adrenergic Agents; Animals; Autonomic Nervous System Diseases; Dopamine beta-Hydroxylase; Embryo, Ma | 2015 |
In vivo model with targeted cAMP biosensor reveals changes in receptor-microdomain communication in cardiac disease.
Topics: Adrenergic beta-Agonists; Animals; Biosensing Techniques; Calcium-Binding Proteins; Cardiomegaly; Ce | 2015 |
Terminalia arjuna (Roxb.) Wight & Arn. augments cardioprotection via antioxidant and antiapoptotic cascade in isoproterenol induced cardiotoxicity in rats.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cytoprotection; Disease Models, Animal; Heart Diseases | 2015 |
A Moderate Carnitine Deficiency Exacerbates Isoproterenol-Induced Myocardial Injury in Rats.
Topics: Animals; Cardiomyopathies; Carnitine; Diastole; Heart; Heart Diseases; Heart Rate; Hyperammonemia; I | 2016 |
Maternal inflammation activated ROS-p38 MAPK predisposes offspring to heart damages caused by isoproterenol via augmenting ROS generation.
Topics: Animals; Antioxidants; Female; Heart; Heart Diseases; Imidazoles; Inflammation; Isoproterenol; Male; | 2016 |
Chlorogenic acid ameliorates isoproterenol-induced myocardial injury in rats by stabilizing mitochondrial and lysosomal enzymes.
Topics: Animals; Arrhythmias, Cardiac; Chlorogenic Acid; Enzyme Activation; Heart Diseases; Isoproterenol; L | 2017 |
Screening, verification, and analysis of biomarkers for drug-induced cardiac toxicity in vitro based on RTCA coupled with PCR Array technology.
Topics: Animals; Animals, Newborn; Cardiotoxicity; Cells, Cultured; Dose-Response Relationship, Drug; Doxoru | 2017 |
Ultrasensitive cross-species measurement of cardiac troponin-I using the Erenna immunoassay system.
Topics: Animals; Biomarkers; Dogs; Female; Heart Diseases; Humans; Immunoassay; Isoproterenol; Linear Models | 2008 |
Direct administration of rutin does not protect against catecholamine cardiotoxicity.
Topics: Adrenergic beta-Agonists; Animals; Cardiac Output; Catecholamines; Chelating Agents; Data Interpreta | 2009 |
Qualification of cardiac troponin I concentration in mouse serum using isoproterenol and implementation in pharmacology studies to accelerate drug development.
Topics: Animals; Aspartate Aminotransferases; Biomarkers; Cardiotonic Agents; Creatine Kinase; Dose-Response | 2009 |
Myostatin represses physiological hypertrophy of the heart and excitation-contraction coupling.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Cardiomegaly; Cell Differentiation; Cell Line; Cell Prol | 2009 |
Take it to heart: myostatin inhibition, mighty mouse and the quest for a competitive edge.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Cardiomegaly; Cell Differentiation; Cell Line; Cell Prol | 2009 |
Protective effect of Artemisia afra Jacq. on isoproterenol-induced myocardial injury in Wistar rats.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Artemisia; Enzymes; Heart Diseases; Isoproterenol; | 2010 |
Pomegranate (Punica granatum L.) juice supplementation attenuates isoproterenol-induced cardiac necrosis in rats.
Topics: Adenosine Triphosphatases; Adrenergic beta-Agonists; Animals; Antioxidants; Beverages; Creatine Kina | 2010 |
Protective effects of rutin on mitochondrial damage in isoproterenol-induced cardiotoxic rats: an in vivo and in vitro study.
Topics: Adenosine Triphosphatases; Adrenergic beta-Agonists; Animals; Antioxidants; Electron Transport; Elec | 2010 |
Cardioprotective effect of lemon grass as evidenced by biochemical and histopathological changes in experimentally induced cardiotoxicity.
Topics: Animals; Antioxidants; Cymbopogon; Disease Models, Animal; Dose-Response Relationship, Drug; Heart D | 2011 |
Crocus sativus L. (saffron) attenuates isoproterenol-induced myocardial injury via preserving cardiac functions and strengthening antioxidant defense system.
Topics: Animals; Antioxidants; Cardiotonic Agents; Crocus; Disease Models, Animal; Heart; Heart Diseases; He | 2012 |
Spironolactone decreases isoproterenol-induced ventricular fibrosis and matrix metalloproteinase-2 in rats.
Topics: Animals; Fibrosis; Gene Expression Regulation, Enzymologic; Heart Diseases; Isoproterenol; Male; Mat | 2011 |
Valsartan, an angiotensin II receptor blocker, attenuates cardiac dysfunction and oxidative stress in isoproterenol-induced cardiotoxicity.
Topics: Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cardiotonic Agents; Cardiotoxins; Heart D | 2011 |
Seabuckthorn attenuates cardiac dysfunction and oxidative stress in isoproterenol-induced cardiotoxicity in rats.
Topics: Animals; Antioxidants; Blood Pressure; Catalase; Creatine Kinase, MB Form; Disease Models, Animal; G | 2011 |
Protective effect of Emblica officinalis (amla) on isoproterenol-induced cardiotoxicity in rats.
Topics: Analysis of Variance; Animals; Antioxidants; Biomarkers; Blood Pressure; Cardiotonic Agents; Cardiot | 2012 |
Cardiomyocyte-restricted inhibition of G protein-coupled receptor kinase-3 attenuates cardiac dysfunction after chronic pressure overload.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Cardiomegaly; Endomyocardial Fibrosis; G-Prote | 2012 |
Sulfur dioxide restores calcium homeostasis disturbance in rat with isoproterenol-induced myocardial injury.
Topics: Animals; Blotting, Western; Calcium; Cardiotonic Agents; Disease Models, Animal; Heart Diseases; Hea | 2012 |
Inhibitory effect of β-hydroxybutyric acid on L-type Ca(2+) current under β-adrenergic stimulation in guinea pig cardiac ventricular myocytes.
Topics: 3-Hydroxybutyric Acid; Adrenergic beta-Agonists; Animals; Calcium Channels, L-Type; GTP-Binding Prot | 2012 |
Cardioprotective potential of N,α-L-rhamnopyranosyl vincosamide, an indole alkaloid, isolated from the leaves of Moringa oleifera in isoproterenol induced cardiotoxic rats: in vivo and in vitro studies.
Topics: Animals; Cardiotonic Agents; Cardiotoxins; Free Radical Scavengers; Heart Diseases; Indole Alkaloids | 2013 |
Myocardial toxicity of arsenic trioxide in a mouse model.
Topics: Adrenergic beta-Agonists; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; B | 2002 |
The effect of breed, age, and sex on myocardial necrosis produced by isoproterenol in the rat.
Topics: Aging; Animals; Cardiomyopathies; Disease; Heart Diseases; Isoproterenol; Myocardial Infarction; Myo | 1959 |
The influence of adrenal cortical steroids on cardiac necrosis produced by isoproterenol.
Topics: Adrenal Cortex Hormones; Heart; Heart Diseases; Humans; Isoproterenol; Necrosis; Sympathomimetics | 1959 |
[The indications for isopropylnoradrenalin sulfate in heart disease].
Topics: Arrhythmias, Cardiac; Coronary Disease; Heart Block; Heart Diseases; Isoproterenol; Sulfates | 1962 |
Reversible obstruction of the ventricular outflow tract.
Topics: Aortic Valve Stenosis; Heart Diseases; Heart Ventricles; Humans; Isoproterenol | 1963 |
EFFECT OF BRONCHODILATOR AEROSOL ON VENTILATORY CAPACITY IN CHRONIC LUNG AND HEART DISEASES.
Topics: Aerosols; Asthma; Bronchitis; Bronchodilator Agents; Heart Diseases; Heart Valve Diseases; Humans; I | 1963 |
[RECURRENCE OF BRONCHIAL ASTHMA, FACTORS CAUSING EXACERBATION AND THERAPY].
Topics: Aminophylline; Anti-Allergic Agents; Asthma; Autonomic Nervous System Diseases; Ephedrine; Epinephri | 1963 |
[METABOLISM OF SEROTONIN. IV. DEPLETING EFFECT OF GM-16462].
Topics: Biliary Dyskinesia; Bronchitis; Glomerulonephritis; Heart Diseases; Hypertension; Isoproterenol; Leu | 1963 |
CARDIAC FUNCTION IN PRIMARY MYOCARDIAL DISORDERS. I.
Topics: Angiocardiography; Blood Pressure Determination; Cardiac Catheterization; Cardiac Surgical Procedure | 1964 |
DEATH FROM "WASP" STING.
Topics: Anaphylaxis; Animals; Bites and Stings; Death, Sudden; Heart Diseases; Humans; Insect Bites and Stin | 1964 |
ISOPROTERENOL-INDUCED MYOCARDIAL NECROSIS. A HISTOCHEMICAL AND ELECTRON MICROSCOPIC STUDY.
Topics: Coronary Disease; Electron Transport Complex IV; Electrons; Fluorescence; Glycogen; Heart Diseases; | 1964 |
TAURINE EXCRETION FOLLOWING DRUG-INDUCED MUSCLE NECROSIS AND X-IRRADIATION.
Topics: Diaphragm; Heart Diseases; Isoproterenol; Muscular Diseases; Necrosis; Radiation Injuries; Radiation | 1964 |
THE EXPERIMENTAL PRODUCTION OF HYPERTROPHIC SUBAORTIC STENOSIS.
Topics: Angiocardiography; Animals; Aortic Coarctation; Cardiac Catheterization; Cardiomyopathy, Hypertrophi | 1964 |
STUDIES IN CARDIAC NECROSIS. I. PRODUCTION OF CARDIAC LESIONS WITH SYMPATHOMIMETIC AMINES.
Topics: Amphetamine; Amphetamines; Animals; Cats; Cricetinae; Dogs; Ephedrine; Epinephrine; Heart Diseases; | 1965 |
STUDIES IN CARDIAC NECROSIS. II. CARDIOVASCULAR EFFECTS OF SYMPATHOMIMETIC AMINES PRODUCING CARDIAC LESIONS.
Topics: Blood Flow Velocity; Cats; Ephedrine; Heart; Heart Diseases; Heart Function Tests; Heart Rate; Isopr | 1965 |
MUSCULAR SUBAORTIC STENOSIS; THE INTERRELATION OF WALL TENSION, OUTFLOW TRACT "DISTENDING PRESSURE" AND ORIFICE RADIUS.
Topics: Amyl Nitrite; Angiotensins; Blood Pressure; Cardiac Catheterization; Cardiac Surgical Procedures; Ca | 1965 |
STUDIES IN CARDIAC NECROSIS. 3. METABOLIC EFFECTS OF SYMPATHOMIMETIC AMINES PRODUCING CARDIAC LESIONS.
Topics: Blood; Blood Glucose; Cats; Ephedrine; Fatty Acids; Glucose; Heart; Heart Diseases; Isoproterenol; M | 1965 |
EFFECT OF LEFT VENTRICULAR SIZE AND SHAPE UPON THE HEMODYNAMICS OF SUBAORTIC STENOSIS.
Topics: Angiocardiography; Blood Pressure; Cardiac Catheterization; Cardiomyopathies; Cardiomyopathy, Hypert | 1965 |
[ELECTRON MICROSCOPIC STUDIES ON MYOCARDIAL LESIONS CAUSED BY ALUDRIN (ISOPROTERENOL SULFATE)].
Topics: Electrons; Heart Diseases; Hypoxia; Isoproterenol; Microscopy; Microscopy, Electron; Rats; Research; | 1965 |
RESULTS OF SURGICAL TREATMENT OF PATIENTS WITH DIFFUSE SUBVALVULAR AORTIC STENOSIS.
Topics: Adolescent; Aged; Angiocardiography; Aortic Stenosis, Subvalvular; Cardiac Surgical Procedures; Card | 1965 |
[ON THE PATHOGENESIS AND PHARMACOLOGICAL INFLUENCE OF MYOCARDIAL NECROSES CAUSED BY ISOPRENALINE POISONING].
Topics: Heart Diseases; Isoproterenol; Myocardial Infarction; Rats; Research; Toxicology | 1964 |
HEMODYNAMICS DURING THE CHRONIC STAGE OF MYOCARDIAL DAMAGE CAUSED BY ISOPROTERENOL.
Topics: Blood Circulation; Blood Pressure; Body Weight; Cardiac Output; Heart Diseases; Heart Rate; Hemodyna | 1964 |
Long-term outcome of patients with recurrent syncope of unknown cause in the absence of organic heart disease and relation to results of baseline tilt table testing.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Comorbidity; Female; Follow-Up Studies; Heart Diseases; Hu | 2003 |
Isoproterenol-produced damage in amphibian heart could be mediated by adrenergic receptors located in the heart muscle.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Ambystoma; Animals; Dose-Response Relationshi | 2004 |
Limited additional release of cardiac troponin I and T in isoproterenol-treated beagle dogs with cardiac injury.
Topics: Adrenergic beta-Agonists; Animals; Biomarkers; Creatine Kinase; Disease Models, Animal; Dogs; Female | 2005 |
PM-induced cardiac oxidative stress and dysfunction are mediated by autonomic stimulation.
Topics: Acetylcholine; Acetylcysteine; Air Pollutants; Animals; Autonomic Agents; Autonomic Nervous System; | 2005 |
Animal models of cardiac fibrosis.
Topics: Aldosterone; Angiotensin II; Animals; Disease Models, Animal; Fibroblasts; Fibrosis; Heart Diseases; | 2005 |
Preventive effect of S-allylcysteine on lipid peroxides and antioxidants in normal and isoproterenol-induced cardiotoxicity in rats: a histopathological study.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Ascorbic Acid; Cysteine; Glutathione; Heart Disease | 2006 |
Ferulic acid with ascorbic acid synergistically extenuates the mitochondrial dysfunction during beta-adrenergic catecholamine induced cardiotoxicity in rats.
Topics: Adrenergic beta-Agonists; Animals; Ascorbic Acid; Coumaric Acids; Cytochromes; Drug Synergism; Gluta | 2006 |
Efficacy of mangiferin on serum and heart tissue lipids in rats subjected to isoproterenol induced cardiotoxicity.
Topics: Adrenergic beta-Agonists; Animals; Cardiotonic Agents; Cholesterol; Fatty Acids, Nonesterified; Hear | 2006 |
Preventive effect of naringin on lipid peroxides and antioxidants in isoproterenol-induced cardiotoxicity in Wistar rats: biochemical and histopathological evidences.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Ascorbic Acid; Ceruloplasmin; Enzymes; Flavanones; | 2006 |
Magnesium attenuates isoproterenol-induced acute cardiac dysfunction and beta-adrenergic desensitization.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Dogs; Female; Heart Diseases; Isoproterenol; Magnesium; Ma | 2007 |
S-allylcysteine ameliorates isoproterenol-induced cardiac toxicity in rats by stabilizing cardiac mitochondrial and lysosomal enzymes.
Topics: Adrenergic beta-Agonists; alpha-Tocopherol; Animals; Antineoplastic Agents; Cysteine; Electrocardiog | 2007 |
Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis.
Topics: Amino Acid Sequence; Animals; Biomarkers; Chromatography, Liquid; Heart Diseases; Immunoprecipitatio | 2007 |
Characterization of troponin responses in isoproterenol-induced cardiac injury in the Hanover Wistar rat.
Topics: Adrenergic beta-Agonists; Animals; Biomarkers; Creatine Kinase; Female; Heart Diseases; Isoenzymes; | 2007 |
Isoproterenol-induced impairment of heart function and remodeling are attenuated by the nonpeptide angiotensin-(1-7) analogue AVE 0991.
Topics: Angiotensins; Animals; Cardiomegaly; Collagen; Disease Models, Animal; Extracellular Matrix; Fibrone | 2007 |
Pulmonary blood volume in rheumatic heart disease and its alteration by isoproterenol.
Topics: Blood Volume; Cardiotonic Agents; Heart Diseases; Hemodynamics; Humans; Isoproterenol; Lung; Male; M | 1963 |
Quantification of cardiac fibrosis by colour-subtractive computer-assisted image analysis.
Topics: Animals; Color; Fibrosis; Heart Diseases; Image Processing, Computer-Assisted; Isoproterenol; Male; | 2008 |
Quantitative evaluation of morphologic changes in experimentally induced myocardial necrosis.
Topics: Animals; Guanethidine; Heart Diseases; Iproniazid; Isoproterenol; Male; Monoamine Oxidase Inhibitors | 1966 |
A study of the period of isovolumic relaxation in normal subjects and in patients with heart disease.
Topics: Adolescent; Adult; Aged; Amyl Nitrite; Blood Pressure; Cardiac Output; Female; Heart Atria; Heart Di | 1967 |
Death in asthmatics.
Topics: Adult; Aerosols; Aged; Asthma; Chlorpromazine; Female; Heart Diseases; Humans; Isoproterenol; Male; | 1967 |
Survival of stressed rats following experimental cardiac necrosis.
Topics: Animals; Dietary Fats; Heart Diseases; Isoproterenol; Male; Necrosis; Physical Exertion; Rats; Stres | 1967 |
Effects of a hydrazine monoamine oxidase inhibitor (phenelzine) on isoproterenol-induced myocardiopathies in the rat.
Topics: Animals; Blood Pressure; Female; Heart Diseases; Heart Rate; Iproniazid; Isoniazid; Isoproterenol; M | 1967 |
Isoproterenol-induced right ventricular infundibular obstruction. Study in adult with a large ventricular septal defect.
Topics: Adult; Blood Pressure; Cardiac Catheterization; Heart Diseases; Heart Septal Defects, Ventricular; H | 1967 |
Comparative investigation on the cardio-protective action of the beta-blockers carazolol, propranolol and pindolol in rats.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Disease; Glycogen; Heart Diseases; Isoproterenol; Mem | 1981 |
Applications and limitations of end-systolic measures of ventricular performance.
Topics: Animals; Cardiomegaly; Chronic Disease; Dogs; Heart Diseases; Heart Function Tests; Heart Ventricles | 1984 |
Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol.
Topics: Adolescent; Adult; Calcium; Female; Heart Diseases; Humans; In Vitro Techniques; Isoproterenol; Male | 1983 |
[Decline of lymphocyte c-AMP synthesis by beta adrenergic stimulation in cardiac insufficiency].
Topics: Adult; Aged; Cyclic AMP; Heart Diseases; Humans; Isoproterenol; Lymphocytes; Middle Aged; Norepineph | 1983 |
Influence of motor activity on the development of isoprenaline induced heart lesions.
Topics: Aging; Animals; Body Weight; Heart Diseases; Isoproterenol; Male; Motor Activity; Rats; Rats, Inbred | 1983 |
Protective effect of isoprenaline pretreatment on the cardiotoxic effect of the same drug.
Topics: Age Factors; Animals; Body Weight; Drug Resistance; Female; Heart Diseases; Isoproterenol; Male; Myo | 1983 |
Electrophysiologic studies in nonsustained ventricular tachycardia: relation to underlying heart disease.
Topics: Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Cardiomyopathy, Hypertrophic; Coronary Disease; | 1983 |
[Use of long term administration of ATP in repeated heart injury with isoprenaline and its effect on the reparative process in the myocardium].
Topics: Adenosine Triphosphate; Animals; Heart; Heart Diseases; Isoproterenol; Male; Myocardium; Rats; Rats, | 1983 |
Measurement of effects of the Chinese herbal medicine higenamine on left ventricular function using a cardiac probe.
Topics: Adult; Alkaloids; Cardiac Output; Dose-Response Relationship, Drug; Female; Heart Diseases; Heart Ra | 1983 |
Adrenergic hyperactivity and cardiac abnormality in primary disorders of sleep.
Topics: Adult; Aged; Arrhythmias, Cardiac; Catecholamines; Female; Heart Diseases; Heart Rate; Humans; Isopr | 1980 |
[Significance of non-invasive parameter (PSP/ESVI) in assessing left ventricular contractility (author's transl)].
Topics: Adolescent; Adult; Aged; Blood Pressure; Echocardiography; Electrocardiography; Heart Diseases; Hear | 1981 |
Effects of isoproterenol and methoxamine on the contents of taurine in rat tissues.
Topics: Amino Acids; Animals; Creatine Kinase; Heart Diseases; Isoproterenol; Liver; Male; Methoxamine; Musc | 1980 |
Response of the left ventricle to stress: effects of exercise, atrial pacing, afterload stress and drugs.
Topics: Animals; Blood Volume; Cardiac Pacing, Artificial; Coronary Disease; Dogs; Echocardiography; Exercis | 1981 |
[An analysis of the responses to the tilt-table test depending on the clinical characteristics of the syncopal episodes in patients without apparent cardiopathy].
Topics: Adult; Aged; Chi-Square Distribution; Electrophysiology; Female; Heart Diseases; Hemodynamics; Human | 1993 |
Isoproterenol tilt-table testing in patients with syncope and structural heart disease.
Topics: Adrenergic beta-Agonists; Aged; Female; Heart Diseases; Hemodynamics; Humans; Isoproterenol; Male; M | 1996 |
Spontaneous reversibility of catecholamine-induced cardiotoxicity in rats.
Topics: Adenylyl Cyclases; Animals; Body Weight; Calcium Channels; Dose-Response Relationship, Drug; Epineph | 1995 |
Abnormal immunostaining for dystrophin in isoproterenol-induced acute myocardial injury in rats: evidence for change in dystrophin in the absence of genetic defect.
Topics: Actins; Animals; Cardiotonic Agents; Cytoplasm; Dystrophin; Edema; Eosine Yellowish-(YS); Heart Dise | 1997 |
An inhibitor of nitric oxide synthase does not increase contraction or beta-adrenoceptor sensitivity of ventricular myocytes from failing human heart.
Topics: Adrenergic beta-Agonists; Adult; Aged; Analysis of Variance; Cell Size; Cells, Cultured; Child; Dose | 1998 |
Comparison of the diagnostic value of cardiac troponin I and T determinations for detecting early myocardial damage and the relationship with histological findings after isoprenaline-induced cardiac injury in rats.
Topics: Animals; Antibodies, Monoclonal; Cardiomyopathies; Creatine Kinase; Heart Diseases; Isoproterenol; K | 2000 |
Effect of acute intravenous administration of isoproterenol on cardiorenal hemodynamics in man.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Animals; Cardiac Output; Dogs; Female; Heart Diseases; | 1968 |
Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent.
Topics: Animals; Antibodies, Monoclonal; CD3 Complex; Cyclosporine; Female; Fibroblast Growth Factor 2; Gene | 2002 |
Effects of angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor blocker on cardiac dysfunction induced by isoproterenol in dogs.
Topics: Adrenergic beta-Agonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting E | 2001 |
Effects of gender on the cardiac toxicity elicited by chronic ethanol intake in rats.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Central Nervous System Depressants; Electric Stimula | 2002 |
Tissue water and pH in experimental primary cardiomyopathy induced by isoproterenol in frog.
Topics: Animals; Anura; Body Water; Extracellular Space; Female; Heart Diseases; Hydrogen-Ion Concentration; | 1975 |
Force development of isoproterenol-damaged frog heart muscle in cyanide anoxia.
Topics: Animals; Anura; Bicarbonates; Cyanides; Heart; Heart Diseases; Hydrogen-Ion Concentration; Hypoxia; | 1975 |
[Hemodynamic aspect of post ECC cardiac failures. Study of 193 cases].
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Blood Pressure; Cardiac Output; Cardiac Surgical | 1977 |
[Tetrapolar rheography in the study of pharmacodynamics of cardiotonic agents].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Glucagon; Heart Diseases; Humans; Hypertension; Isoprotere | 1978 |
The influence of hypoxia and hypercapnia on the cardiotoxicity of isoprenaline in dogs [proceedings].
Topics: Animals; Dogs; Heart Diseases; Hypercapnia; Hypoxia; Isoproterenol | 1978 |
The influence of arterial pH control on the cardiotoxicity of isoprenaline in hypoxic dogs [proceedings].
Topics: Animals; Arteries; Blood Chemical Analysis; Dogs; Heart Diseases; Hydrogen-Ion Concentration; Hypoxi | 1979 |
Exeriences with isoprenaline induced myocardial necrosis in the rat.
Topics: Animals; Cats; Heart Diseases; Isoproterenol; Male; Myocardium; Necrosis; Rats; Staining and Labelin | 1976 |
Echocardiographic determination of left ventricular stress-velocity relations.
Topics: Adolescent; Adult; Aged; Angiocardiography; Aortic Valve Insufficiency; Aortic Valve Stenosis; Cardi | 1975 |
Induction of necrosis and failure in the isolated perfused rat heart with oxidized isoproterenol.
Topics: Animals; Cardiomegaly; Drug Stability; Heart; Heart Diseases; Isoproterenol; Male; Microscopy, Elect | 1975 |
Comparison of heart sarcolemmal enzyme activities in normal and cardiomyopathic (UM-X7.1) hamsters.
Topics: Adenosine Triphosphatases; Adenylyl Cyclases; Animals; Calcium; Cricetinae; Disease Models, Animal; | 1976 |
Low plasma ionized calcium and response to calcium therapy in critically ill man.
Topics: Adolescent; Adult; Blood Transfusion; Calcium; Calcium Chloride; Heart Diseases; Humans; Hydrogen-Io | 1975 |
[Changes in pulmonary compliance after aerosol administration of isoprenaline in cardiac patients].
Topics: Adult; Aerosols; Aged; Female; Heart Diseases; Humans; Isoproterenol; Lung; Lung Compliance; Male; M | 1977 |
[Echocardiography during the therapy of cardiovascular diseases].
Topics: Calcium Chloride; Digoxin; Echocardiography; Heart Diseases; Heart Ventricles; Humans; Isoproterenol | 1977 |
Effect of isoproterenol on the "early repolarization" syndrome.
Topics: Adult; Aged; Cardiomyopathies; Electrocardiography; Electrophysiology; Female; Heart; Heart Diseases | 1979 |
Bedside maneuvers in the diagnosis of heart disease.
Topics: Adolescent; Adult; Diagnosis, Differential; Heart Auscultation; Heart Defects, Congenital; Heart Dis | 1979 |
[Changes in precordial movements in non-ischaemic heart disease patients after i.v. administration of isoproterenol and dopamine. Comparison between normal and cardiopathic subjects (author's transl)].
Topics: Adolescent; Adult; Cardiomyopathies; Child; Dopamine; Electrocardiography; Female; Heart Diseases; H | 1979 |
Morphological changes observed after stimulation or inhibition of adrenic system in rats chronically treated with hydrazinophtalazines.
Topics: Animals; Catecholamines; Epinephrine; Heart; Heart Diseases; Hemorrhage; Hydralazine; Inflammation; | 1979 |
[Mechanism of the cardioprotective effect of triamterene in the rat heart. Myocardial protection via elevation of extracellular K+ and Mg++ concentrations].
Topics: Animals; Calcium; Diuresis; Heart; Heart Diseases; Isoproterenol; Magnesium; Male; Myocardium; Potas | 1977 |
The influence of triamterene on isoproterenol-induced and spontaneous myocardial calcium uptake in cardiomyopathic hamsters.
Topics: Animals; Calcium; Cricetinae; Female; Heart; Heart Diseases; Isoproterenol; Magnesium; Male; Mesocri | 1977 |
Isoprenaline-induced myocardial necrosis in dogs.
Topics: Animals; Dogs; Electrocardiography; Enzymes; Female; Heart Diseases; Isoproterenol; Male; Myocardium | 1978 |
Cardiac toxicities of antibiotics.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Calcium; Digoxin; Gentamicins; Guinea Pigs; Heart D | 1978 |
Effects of dopamine on haemodynamics and myocardial energetics in man: comparison with effects of isoprenaline and L-noradrenaline.
Topics: Adult; Cardiac Output; Catecholamines; Coronary Circulation; Dopamine; Female; Heart; Heart Diseases | 1978 |
Impairment of autonomically mediated heart rate control in patients with cardiac dysfunction.
Topics: Adolescent; Adult; Atropine; Autonomic Nervous System; Cardiomyopathies; Exercise Test; Female; Hear | 1975 |
Acute cobalt and isoproterenol cardiotoxicity in swine: protection by selenium-vitamin E supplementation and potentiation by stress-susceptible phenotype.
Topics: Animals; Cobalt; Heart Diseases; Isoproterenol; Male; Myocardium; Phenotype; Selenium; Stress, Physi | 1977 |
[Relationship between the mosaicism of myocardial damage and the metabolic heterogeneity of myocardiocytes].
Topics: Animals; Heart Diseases; Isoproterenol; Male; Mice; Mice, Inbred Strains; Myocardium; RNA | 1977 |
Isoproterenol-induced cardiomyopathy: changes in cardiac enzymes and protection by methylprednisolone.
Topics: Animals; Cathepsins; Creatine Kinase; Heart Diseases; Hexosaminidases; Hydrolases; Isoproterenol; Ma | 1977 |
The effect of anti-lipolytic agents on isoprenaline-induced myocardial necrosis in the rat.
Topics: Animals; Fatty Acids, Nonesterified; Fever; Heart Diseases; Isoproterenol; Male; Myocardium; Necrosi | 1977 |
Assessment of cardiac performance with quantitative radionuclide angiocardiography: sequential left ventricular ejection fraction, normalized left ventricular ejection rate, and regional wall motion.
Topics: Adult; Aged; Angiocardiography; Blood Pressure; Cardiac Output; Heart Diseases; Heart Rate; Heart Ve | 1977 |
Evaluation of pressure-derived indices of right ventricular contractility.
Topics: Blood Flow Velocity; Blood Pressure; Heart Diseases; Heart Rate; Humans; Isoproterenol; Myocardial C | 1977 |
Effects of prolonged tolbutamide treatment on plasma glucose concentrations and isoproterenol-induced cardiac lesions in rats.
Topics: Animals; Blood Glucose; Body Weight; Drug Interactions; Female; Heart Diseases; Isoproterenol; Male; | 1977 |
Effect of body temperature on cardiotoxicity of isoprenaline in rats.
Topics: Animals; Blood Pressure; Body Temperature; Body Temperature Regulation; Dose-Response Relationship, | 1976 |
[The epidemic of asthma mortality in the 1960's. Aerosol spray as cause of the deaths].
Topics: Aerosols; Asthma; Heart Diseases; Humans; Isoproterenol | 1976 |
[Influence of trimepranol and practolol on the heart damaged by isoprenaline].
Topics: Animals; Disease Models, Animal; Heart Diseases; Isoproterenol; Phenyl Ethers; Practolol; Propanolam | 1976 |
Influencing heart necroses caused by application of isoproterenol, potassium orotat.
Topics: Animals; Female; Heart Diseases; Isoproterenol; Male; Necrosis; Orotic Acid; Rats | 1976 |
On the clinical value of calibrated displacement apexcardiography.
Topics: Adolescent; Adult; Aortic Valve Insufficiency; Aortic Valve Stenosis; Blood Pressure; Coronary Disea | 1975 |
[Letter: Intoxication with chloroquine with cardiac disorders. Effect of isoprenaline].
Topics: Adolescent; Chloroquine; Heart Diseases; Humans; Hypotension; Isoproterenol; Male; Shock, Cardiogeni | 1975 |
Isoprenaline-induced cardiac necroses in normotensive and in spontaneously hypertensive rats.
Topics: Animals; Disease Models, Animal; Electrocardiography; Female; Heart Diseases; Hypertension; Isoprote | 1975 |
Stress-induced and sympathetically-mediated electrocardiographic and circulatory variations in the primary hyperkinetic heart syndrome.
Topics: Adolescent; Adult; Atropine; Electrocardiography; Heart Diseases; Hemodynamics; Humans; Isoprotereno | 1975 |
[Synthesis and characteristics of proteins in inner mitochondrial membranes of the myocardium of rats with disseminated necrotic heart diseases].
Topics: Animals; Heart Diseases; Isoproterenol; Male; Membranes; Mitochondria; Molecular Weight; Muscle Prot | 1975 |
beta Adrenergic receptor desensitisation may serve a cardioprotective role.
Topics: Adrenergic beta-Antagonists; Animals; Heart; Heart Diseases; Hypothyroidism; Infusion Pumps; Injecti | 1992 |
Effect of iloprost on serum creatine kinase and lactate dehydrogenase isoenzymes after isoprenaline-induced cardiac damage in rats.
Topics: Animals; Creatine Kinase; Epoprostenol; Heart Diseases; Iloprost; Isoenzymes; Isoproterenol; L-Lacta | 1990 |
Isoprenaline-induced increase in mRNA levels of inhibitory G-protein alpha-subunits in rat heart.
Topics: Animals; Autoradiography; Blotting, Northern; Cardiomegaly; GTP-Binding Proteins; Heart Diseases; He | 1991 |
Complex ventricular ectopic activity in patients less than 20 years of age with or without syncope, and the role of ventricular extrastimulus testing.
Topics: Adolescent; Adult; Child; Child, Preschool; Echocardiography; Electrocardiography; Female; Heart Dis | 1991 |
Safety and efficacy of oral flecainide therapy in patients with atrioventricular re-entrant tachycardia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Pacing, Artificial; Child; Electric Stimulation; | 1991 |
[Functional tests in cardiology].
Topics: Coronary Disease; Dipyridamole; Echocardiography; Electrocardiography; Ergonovine; Exercise Test; He | 1991 |
Cardiotoxicity of hydralazine and minoxidil in the rat. Influence of age.
Topics: Aging; Animals; Blood Pressure; Heart Diseases; Heart Rate; Hydralazine; Isoproterenol; Minoxidil; M | 1991 |
Reduced positive inotropic effects in diseased human ventricular myocardium.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Aged; Calcium; Dobutamine; Dopamine; Dose-Response Relationship, | 1986 |
Protection against isoproterenol-induced myocardial necrosis in rats by 6-mercaptopurine and 6-thioguanine or by irradiation.
Topics: Allopurinol; Animals; Heart Diseases; Isoproterenol; Leukocytes; Leukopenia; Male; Mercaptopurine; M | 1989 |
Left ventricular sensitivity to beta-adrenoceptor-stimulating drugs in patients with ischemic heart disease and varying degrees of ventricular dysfunction.
Topics: Aged; Coronary Disease; Dose-Response Relationship, Drug; Female; Heart; Heart Diseases; Heart Ventr | 1987 |
T3 treatment does not prevent myocardial dysfunction in chronically diabetic rats.
Topics: Animals; Caprylates; Cytochrome c Group; Diabetes Mellitus, Experimental; Half-Life; Heart Diseases; | 1988 |
Cardiotoxicity of high doses of isoproterenol on cardiac haemodynamics and metabolism in SHR and WKY rats.
Topics: Animals; Cardiomegaly; Dose-Response Relationship, Drug; Energy Metabolism; Heart Diseases; Hemodyna | 1985 |
Temporal relationship between early systolic closure of the aortic valve and aortic flow: experimental study with and without systolic anterior motion of the mitral valve.
Topics: Animals; Aorta; Aortic Valve; Blood Flow Velocity; Blood Pressure; Dobutamine; Dogs; Echocardiograph | 1986 |
Developmental considerations in neonatal failure.
Topics: Aging; Animals; Blood Circulation; Body Temperature Regulation; Cardiac Output; Digitalis; Digoxin; | 1985 |
[Clinical studies with a new beta receptor blocking agent from the indole series (LB 46)].
Topics: Adolescent; Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Atrial Fibrillation; Atrial | 1970 |
[Jervell's cardio-auditory syndrome and multifocal ventricular tachycardia].
Topics: Adams-Stokes Syndrome; Adolescent; Adrenergic beta-Antagonists; Adult; Cardiac Complexes, Premature; | 1972 |
Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine.
Topics: Aortic Valve; Blood Pressure; Cardiac Output; Catecholamines; Coronary Disease; Female; Heart; Heart | 1974 |
Biochemical changes of myocardial necrosis induced by isoproterenol and protective effects of beta-blocker and anti-inflammatory drugs.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Blood Pressure; Heart Diseases; Hear | 1974 |
Spurious heart disease in athletic children.
Topics: Adolescent; Blood Pressure; Bradycardia; Cardiac Catheterization; Cardiac Output; Cardiomegaly; Diag | 1968 |
An index of the contractile state of the myocardium in man.
Topics: Adolescent; Adult; Cardiac Catheterization; Cardiomegaly; Digitalis Glycosides; Dye Dilution Techniq | 1968 |
Left ventricular performance during the infusion of isoproterenol in patients with valvular heart diseases and idiopathic cardiomegaly.
Topics: Adolescent; Adult; Aortic Valve Insufficiency; Blood Pressure; Cardiac Catheterization; Cardiomegaly | 1968 |
Shift in the lactate dehydrogenase isoenzyme spectrum in isoproterenol-induced acute experimental cardiac necrosis in the rat.
Topics: Animals; Electrophoresis; Female; Heart Diseases; Isoenzymes; Isoproterenol; L-Lactate Dehydrogenase | 1970 |
Effect of age, body weight and body fat on experimental myocardial necrosis.
Topics: Adipose Tissue; Age Factors; Analysis of Variance; Animals; Body Weight; Heart Diseases; Isoproteren | 1970 |
Experimental cardiomegalies and "cardiomegalies" in free-living animals.
Topics: Animals; Birds; Body Weight; Cardiomegaly; Coronary Vessels; Fishes; Heart; Heart Diseases; Isoprote | 1969 |
Effect of necrogenic doses of isoproterenol on the heart of the tench (Tinca tinca--osteoichthyes), the frog (Rana temporaria--anura) and the pigeon (Columba livia--aves).
Topics: Animals; Anura; Coloring Agents; Columbidae; Coronary Vessels; Endoplasmic Reticulum; Fishes; Heart | 1971 |
Proceedings: Changes in myocardial ultrastructure and autoradiographic 45Ca distribution during isoproterenol-induced cardiac necrotization--prevention by Ca-antagonistic compounds.
Topics: Adrenal Cortex Hormones; Animals; Autoradiography; Calcium; Calcium Radioisotopes; Dihydrotachystero | 1974 |
Myosin aggregation in cardiac necroses induced by isoproterenol in rats.
Topics: Adenosine Triphosphate; Animals; Chromatography; Electrophoresis; Heart Diseases; Isoproterenol; Mus | 1970 |
Heart tone.
Topics: Angiotensin II; Animals; Endotoxins; Heart; Heart Diseases; Heart Function Tests; Humans; Isoprotere | 1970 |
Efficacy of isoproterenol-glucagon infusion in patients with heart disease.
Topics: Adult; Aged; Aortic Valve Insufficiency; Aortic Valve Stenosis; Blood Pressure; Cardiac Output; Coro | 1971 |
[The effect of L-aspartic acid in isoproterenol necrosis of cardiac muscle].
Topics: Alanine Transaminase; Amino Acids; Animals; Aspartate Aminotransferases; Aspartic Acid; Heart Diseas | 1972 |
The cardiotoxic effects of pressurized aerosol isoproterenol in the dog.
Topics: Adrenocorticotropic Hormone; Aerosols; Animals; Arrhythmias, Cardiac; Dogs; Electrocardiography; Fem | 1973 |
[The importance of adrenergic beta-receptors for the cardiotoxic action of sympathomimetic amines].
Topics: Animals; Bronchodilator Agents; Epinephrine; Ethanolamines; Heart; Heart Diseases; In Vitro Techniqu | 1965 |
Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.
Topics: Animals; Blood Pressure; Body Weight; DNA; Female; Heart Diseases; Heart Rate; Hydrazines; Iproniazi | 1966 |
Observations on isoprenaline-induced myocardial necroses.
Topics: Animals; Guanethidine; Heart Diseases; Iproniazid; Isoproterenol; Male; Monoamine Oxidase Inhibitors | 1967 |
Competitive antagonism of isoprenaline-induced cardiac necroses by beta-adrenoreceptor blocking agents.
Topics: Animals; Biological Assay; Ethanolamines; Heart Diseases; Injections, Subcutaneous; Isoproterenol; M | 1969 |
The role of cyclic AMP in isoprenaline-induced cardiac necroses in the rat.
Topics: Adenine Nucleotides; Animals; Cyclic AMP; Heart Diseases; Isoproterenol; Male; Myocardium; Necrosis; | 1971 |
[Clinical pharmacology and adverse effects of various anti-arrhythmic drugs].
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Bone Marrow Diseases; Central Nervous Sys | 1971 |
[Group discussion: progress in cardiopathology].
Topics: Adrenergic beta-Antagonists; Coronary Angiography; Coronary Vessels; Extracorporeal Circulation; Glu | 1971 |
Circulatory responses to beta adrenergic blockade with alprenolol. Studies in patients with chronic heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Amino Alcohols; Blood Pressure; Cardiac Output | 1972 |
Pharmacological studies on heart muscle lesions induced by isoproterenol.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amides; Animals; Antihypertensive Agents; | 1969 |
Factors influencing the production of cardiomyopathies by methoxamine and metaraminol.
Topics: Adrenalectomy; Adrenergic beta-Antagonists; Animals; Aortic Aneurysm; Blood Pressure; Diet; Edema; F | 1969 |
Myocardial necroses produced by intravenous infusion of isoprenaline into rats.
Topics: Alanine Transaminase; Animals; Heart Diseases; Infusions, Parenteral; Injections, Intraperitoneal; I | 1971 |
[What is assured in treatment with beta receptor blockaders?].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Cresols; Heart Diseases; Huma | 1972 |
[Advances and prospects in phonomechanocardiography. Reappraisal of the clinical examination].
Topics: Amyl Nitrite; Carotid Arteries; Electrocardiography; Heart Auscultation; Heart Diseases; Heart Funct | 1974 |
Effect of glucose in isoproterenol-induced necrotic heart under anoxic perfusion.
Topics: Adenosine Triphosphate; Animals; Glucose; Glycogen; Heart; Heart Diseases; Hypoxia; Isoproterenol; L | 1974 |
Electron microscopic studies on isoproterenol-induced myocardial lesion in rats.
Topics: Animals; Calcium; Coronary Disease; Endoplasmic Reticulum; Glycogen; Heart; Heart Diseases; Histocyt | 1972 |
Systolic time intervals as measures of the contractile state of the left ventricular myocardium in man.
Topics: Biomechanical Phenomena; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiac Volume; Dy | 1972 |
[Effect of K and Mg asparaginate on the structure of isoprenaline-induced myocardial necrosis in the rabbit].
Topics: Animals; Asparagine; Heart; Heart Diseases; Isoproterenol; Magnesium; Male; Microscopy, Electron; Ne | 1972 |
Healing of myocardial necrosis caused by sympathomimetic amines.
Topics: Animals; Calcium; Epinephrine; Heart; Heart Diseases; Isoproterenol; Magnesium; Male; Myocardium; Ne | 1972 |
Myocardial loss of functional magnesium. II. In cardiomyopathies of diverse etiology.
Topics: Adult; Age Factors; Aging; Animals; Calcium; Cricetinae; Heart; Heart Diseases; Heart Failure; Human | 1972 |
Cardiotoxicity of isoproterenol in experimental animals. Influence of stress, obesity, and repeated dosing.
Topics: Animals; Dietary Carbohydrates; Dietary Fats; Dogs; Dose-Response Relationship, Drug; Heart; Heart D | 1972 |
Recent advances in therapy for refractory congestive heart failure.
Topics: Adrenal Cortex Hormones; Aminophylline; Cardiac Catheterization; Cardiomyopathies; Dextrothyroxine; | 1973 |
Electrocardiography and blood chemistry in the detection of myocardial lesions in dogs.
Topics: Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Blood Circulation; Creatine Kinase; Crea | 1973 |
Isoproterenol in cardiology.
Topics: Asthma; Bradycardia; Heart Block; Heart Diseases; Humans; Isoproterenol | 1973 |
Excitation-contraction coupling in heart. XII. Subcellular calcium transport in isoproterenol-induced myocardial necrosis.
Topics: Animals; Calcium; Heart Diseases; Hydrogen-Ion Concentration; Isoproterenol; Microsomes; Mitochondri | 1973 |
[Metabolic effects of isoproterenol in low cardiac output syndrome after open heart surgery].
Topics: Adolescent; Adult; Cardiac Output; Cardiac Surgical Procedures; Child; Heart Diseases; Humans; Isopr | 1973 |
[Effect of dipyridamole and 1-(2-pyridilethyl) isoquinoline on isoprenaline-induced cardiopathy].
Topics: Animals; Dipyridamole; Heart Diseases; Isoproterenol; Isoquinolines; Male; Rats | 1973 |
[Proceedings: Cardiological problems].
Topics: Acidosis; Angiocardiography; Cardiac Catheterization; Cineangiography; Diet Therapy; Digoxin; Diuret | 1973 |
Calorigenic effects of isoproterenol during production of myocardial necrosis in the rat.
Topics: Animals; Heart Diseases; Isoproterenol; Male; Metabolism; Motor Activity; Muscle Contraction; Myocar | 1973 |
[Isoproterenol in cardiologic emergencies].
Topics: Emergencies; Heart Diseases; Humans; Isoproterenol | 1973 |
Effectiveness of heart muscle extract in myocardial necrosis.
Topics: Animals; Heart Diseases; Isoproterenol; Male; Myocardium; Necrosis; Rats; Tissue Extracts | 1973 |
[Effect of preliminary physical training on the distribution of electrolytes in the myocardium and development of isoprenaline lesion of the heart].
Topics: Animals; Female; Heart; Heart Diseases; Heart Ventricles; Humans; Infant; Isoproterenol; Myocardium; | 1973 |
Treatment of nontraumatic cardiac emergencies.
Topics: Adams-Stokes Syndrome; Arrhythmias, Cardiac; Atropine; Bradycardia; Electric Countershock; Emergency | 1974 |
Peculiar myofilament changes near the intercalated disc in isoproterenol-induced cardiac muscle cell injury.
Topics: Animals; Heart; Heart Diseases; Isoproterenol; Microscopy, Electron; Myocardium; Myofibrils; Rats | 1974 |
Subcellular myocardial ionic shifts and mitochondrial alterations in the course of isoproterenol--induced cardiopathy of the rat.
Topics: Animals; Calcium; Heart Diseases; Isoproterenol; Magnesium; Male; Microscopy, Electron; Mitochondria | 1974 |
Determination of cardiac output in man by means of impedance plethysmography.
Topics: Adult; Aged; Cardiac Output; Dye Dilution Technique; Heart Diseases; Humans; Isoproterenol; Male; Mi | 1968 |
Simultaneous determination of the capacity of the vascular bed and capillary blood flow in the normal myocardium of the rat and in two types of experimental necrosis.
Topics: Animals; Blood Volume; Capillaries; Coronary Vessels; Heart Diseases; Hemostasis; Isoproterenol; Nec | 1968 |
The application of fiberoptic indicator-dilution technique to the assessment of myocardial function. II. The interaction of the ejection fraction and end-diastolic volume during exercise and isoproterenol infusion.
Topics: Adolescent; Adult; Cardiac Output; Child; Child, Preschool; Female; Fiber Optic Technology; Heart; H | 1970 |
Hemodynamic evaluation of glucagon in symptomatic heart disease.
Topics: Blood Pressure; Cardiac Catheterization; Cardiac Output; Coronary Disease; Dye Dilution Technique; G | 1971 |
[Apropos of the detection of obstructive cardiomyopathies].
Topics: Amyl Nitrite; Aortic Valve Insufficiency; Aortic Valve Stenosis; Carotid Arteries; Heart Auscultatio | 1968 |
[Value of the carotidogram in idiopathic muscular stenosis of the left ventricle. Study of 50 cases of 1,668 diverse cardiopathies].
Topics: Adolescent; Adult; Aged; Cardiomyopathies; Cardiomyopathy, Hypertrophic; Carotid Arteries; Child; El | 1969 |
Cardiac catheterization and angiocardiography.
Topics: Angiocardiography; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiac Surgical Procedu | 1971 |
Clinical studies on apexcardiogram. 3. Effects of low oxygen inhalation and various pharmacological tests on the apex beat in cardiac patients.
Topics: Amyl Nitrite; Digitalis Glycosides; Electrocardiography; Exercise Test; Heart Diseases; Humans; Isop | 1971 |
Early alterations of the cardiac muscle cells in isoproterenol-induced necrosis.
Topics: Animals; Heart; Heart Diseases; Isoproterenol; Male; Microscopy, Electron; Mitochondria; Muscles; My | 1972 |
Asthma mortality. Why the United States was spared an epidemic of deaths due to asthma.
Topics: Adolescent; Adult; Aerosols; Asthma; Australia; Child; Child, Preschool; Europe; Heart Diseases; Hum | 1972 |
Microscopic evaluation of experimentally induced cardiac necrosis in thiamine-deficient and control rats.
Topics: Animals; Heart Diseases; Injections, Subcutaneous; Isoproterenol; Male; Necrosis; Rats; Rats, Inbred | 1972 |
Circulatory effects of practolol.
Topics: Acetanilides; Amino Alcohols; Blood Pressure; Cardiac Catheterization; Cardiac Output; Depression, C | 1972 |
[Prevention of isoproterenol-induced myocardial necroses by lowering of the plasma calcium level with calcitonin].
Topics: Animals; Calcitonin; Calcium; Drug Interactions; Heart; Heart Diseases; Isoproterenol; Necrosis; Rat | 1972 |
[Effect of Cardilan-Spofa on the experimental isoprenaline necrosis of the myocardium in the rabbit].
Topics: Animals; Asparagine; Heart Diseases; Isoproterenol; Lipid Metabolism; Magnesium; Myocardium; Necrosi | 1972 |
[Effect of K and Mg asparaginate infusions (cardilan Spofa) on LDH isoenzymes in the experimentally injured myocardium].
Topics: Animals; Aspartic Acid; Heart Diseases; Infusions, Parenteral; Isoenzymes; Isoproterenol; L-Lactate | 1972 |
Direct correlation of external systolic time intervals with internal indices of left ventricular function in man.
Topics: Adult; Amyl Nitrite; Cardiac Catheterization; Cardiac Volume; Electrocardiography; Exercise Test; He | 1971 |
Reduced myocardial fibrosis after dimethylsulfoxide (DMSO) treatment of isoproterenol-induced myocardial necrosis in rats.
Topics: Animals; Dimethyl Sulfoxide; Heart Diseases; Hexosamines; Hydroxyproline; Ischemia; Isoproterenol; M | 1971 |
An experimental model of micronecrosis in the myocardium in rats.
Topics: Animals; Disease Models, Animal; Heart Diseases; Injections, Intraperitoneal; Isoproterenol; Myocard | 1971 |
[Effect of ATP-Spofa on the level of total lactate dehydrogenase in the blood of rats following administration of isoprenaline (IP)].
Topics: Adenosine Triphosphate; Animals; Disease Models, Animal; Female; Heart; Heart Diseases; Isoprotereno | 1971 |
Time course of resistance to experimental cardiac necrosis in thiamine-deficient rats.
Topics: Animals; Body Weight; Heart; Heart Diseases; Isoproterenol; Male; Necrosis; Rats; Thiamine Deficienc | 1971 |
Isoproterenol-induced cardiac necrosis.
Topics: Animals; Desoxycorticosterone; Diet; Dogs; Drug Synergism; Female; Heart Diseases; Humans; Isoproter | 1969 |
Histochemical and electron microscopical studies on the cardiac necroses produced by sympathomimetic agents.
Topics: Animals; Carbohydrates; Epinephrine; Glycogen; Heart Diseases; Histocytochemistry; Isoproterenol; Ly | 1969 |
Tissue electrolyte alteration in disseminated myocardial necrosis.
Topics: Animals; Calcium; Electrolytes; Heart Diseases; Isoproterenol; Kidney; Magnesium; Myocardium; Necros | 1969 |
Experimental "metabolic" cardiopathies and their relationship to human heart diseases. Concluding remarks.
Topics: Animals; Cardiomyopathies; Heart Diseases; Heart Failure; Humans; Ischemia; Isoproterenol; Myocardia | 1969 |
Adenine nucleotides of myocardium from rats treated with isoproterenol and-or Mg- or K-deficiency.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Blood Pressure; Body Weight; Diet; Fatty Acids | 1969 |
[Innocent cardiac murmurs in young adults. Clinical and physiological aspects].
Topics: 1-Propanol; Adolescent; Adult; Amyl Nitrite; Diagnosis, Differential; Female; Heart; Heart Auscultat | 1969 |
The influence of alcohol on viral and isoproterenol cardiomyopathy.
Topics: Alcoholic Intoxication; Animals; Coxsackievirus Infections; Ethanol; Heart Diseases; Humans; Isoprot | 1969 |
[Protective effect of organic Ca antagonists (iproveratril, D 600, prenylamine) against isoproterenol-induced myocardial necrosis].
Topics: Animals; Anti-Arrhythmia Agents; Calcium; Heart; Heart Diseases; Isoproterenol; Necrosis; Nitriles; | 1969 |
Isoproterenol-induced cardiac lesions in frog observed in vivo.
Topics: Animals; Anura; Blood Pressure; Disease Models, Animal; Female; Heart; Heart Aneurysm; Heart Disease | 1970 |
Physical activity, body fat and experimental cardiac necrosis.
Topics: Adipose Tissue; Adrenal Glands; Animals; Body Temperature; Body Weight; Heart; Heart Diseases; Isopr | 1970 |
[Effect of preliminary training for altitude hypoxia and cold on the development of sympathomimetic heart disorder].
Topics: Adaptation, Physiological; Altitude; Animals; Cold Temperature; Environmental Exposure; Heart; Heart | 1970 |
LDH isoenzyme spectrum in the myocardium of rats after repeated doses of isoproterenol.
Topics: Anemia; Animals; Heart; Heart Diseases; Hypoxia; Isoenzymes; Isoproterenol; L-Lactate Dehydrogenase; | 1970 |
Limitations of phonocardiographic assessment of ball variance.
Topics: Aged; Aortic Valve Insufficiency; Autopsy; Cineangiography; Diagnosis, Differential; Female; Heart D | 1970 |
Uptake and metabolism of noradrenaline--14C in rats after provoking damage to the heart muscle with isoprenaline.
Topics: Animals; Body Weight; Carbon Isotopes; Heart; Heart Diseases; In Vitro Techniques; Isoproterenol; Ki | 1970 |
[Role of the lysosome system in the preventive effect of adaptation to high-altitude hypoxia in heart diseases].
Topics: Acid Phosphatase; Adaptation, Physiological; Animals; Aortic Coarctation; Deoxyribonucleases; Diseas | 1970 |
[Activity of lysosome enzymes of the myocardium during adaptation to altitudinal hypoxia and heart damage].
Topics: Acid Phosphatase; Adaptation, Physiological; Altitude; Animals; Aortic Coarctation; Deoxyribonucleas | 1970 |
Cardiovascular responses to intravenous isoproterenol infusion in subjects with and without left ventricular hypertrophy.
Topics: Blood Pressure; Cardiac Output; Heart; Heart Diseases; Heart Rate; Heart Ventricles; Humans; Hypertr | 1970 |
Myocardial hypertrophy resulting from low dosage isoproterenol administration in rats.
Topics: Animals; Body Weight; Heart Diseases; Heart Rate; Hypertrophy; Isoproterenol; Organ Size; Rats; Tach | 1971 |
Plasma insulin in heart disease.
Topics: Cardiac Surgical Procedures; Heart Diseases; Heart Failure; Humans; Insulin; Insulin Secretion; Isop | 1971 |
Tissue buffering capacity: its role in the prevention of isoproterenol induced necrosis.
Topics: Animals; Buffers; Heart Diseases; Hydrochloric Acid; Hydrogen-Ion Concentration; Isoproterenol; Male | 1971 |
[On the use of cardioactive drugs in the presence of an electric pacemaker].
Topics: Adrenal Cortex Hormones; Diuretics; Heart Diseases; Humans; Isoproterenol; Lanatosides; Pacemaker, A | 1967 |
[Hemodynamic effects of isoproterenol and propranolol in tetralogy of Fallot--development of anoxic spells and its treatment].
Topics: Adolescent; Angiocardiography; Blood Pressure; Child; Child, Preschool; Cyanosis; Electrocardiograph | 1967 |
[Pulmonary and right heart atrium embolectomy].
Topics: Blood Pressure; Embolism; Heart Atria; Heart Diseases; Heparin; Humans; Isoproterenol; Male; Middle | 1969 |
Peripheral arterial insufficiency. A complication of beta-adrenergic blocking therapy.
Topics: Adult; Blood Circulation; Cardiovascular Diseases; Female; Heart Diseases; Humans; Hypertension; Hys | 1969 |
Functional tests as an aid to cardiac auscultation.
Topics: Adult; Amyl Nitrite; Animals; Child; Child, Preschool; Diagnosis, Differential; Dogs; Heart Ausculta | 1966 |
The protective effect of hyperbaric oxygenation upon isoproterenol-induced myocardial necrosis in Syrian hamsters.
Topics: Animals; Cricetinae; Female; Heart Diseases; Hyperbaric Oxygenation; Isoproterenol; Male; Necrosis | 1966 |
[Beta-adrenergic receptor-blocking agents].
Topics: Catecholamines; Epinephrine; Heart Diseases; Humans; Isoproterenol; Sympatholytics | 1966 |
Isoproterenol in treatment of heart disease. Hemodynamic effects in circulatory failure.
Topics: Adult; Aortic Valve Stenosis; Cardiac Catheterization; Coronary Disease; Female; Heart Diseases; Hum | 1966 |